

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Beyond adhesion:&nbsp;emerging roles for... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/6-1612/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/6-1612" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Beyond adhesion:Â emerging roles for integrins in control of the tumor microenvironment" />
    
            <meta name="og:title" content="F1000Research Article: Beyond adhesion:&amp;nbsp;emerging roles for integrins in control of the tumor microenvironment.">
            <meta name="og:description" content="Read the latest article version by Whitney Longmate, C Michael DiPersio, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="12834">
            <meta name="article-id" content="11877">
            <meta name="dc.title" content="Beyond adhesion:&amp;nbsp;emerging roles for integrins in control of the tumor microenvironment">
            <meta name="dc.description" content="While integrins were originally discovered as cell adhesion receptors, recent studies have reinforced the concept that integrins have central roles in cancer that extend far beyond controlling cell adhesion and migration. Indeed, as transmembrane cell surface receptors that occupy a critical position at the interface of cellular and extracellular interactions and are capable of both &ldquo;inside-out&rdquo; and &ldquo;outside-in&rdquo; signaling, integrins are uniquely poised to regulate the cell&rsquo;s ability to promote, sense, and react to changes in the tumor microenvironment. Moreover, integrins are present on all cell types in the tumor microenvironment, and they have important roles in regulating intercellular communication. Decades of promising pre-clinical studies have implicated certain integrins as attractive therapeutic targets in the cancer clinic. Nevertheless, results of the few clinical trials that target integrins in cancer have thus far been disappointing. Importantly, these clinical failures likely reflect the emerging complexity of individual and combinatorial integrin function within both tumor cells and other cell types of the tumor microenvironment, together with a need to explore integrin-targeting agents not just as monotherapies but also as adjuvants to more conventional radiotherapies or chemotherapies. In this review, we will examine recent advances toward understanding how integrins regulate cancer progression, including their roles in intercellular communication and modulation of the tumor microenvironment. Additionally, we will discuss factors that underlie the limited efficacy of current efforts to target integrins in the cancer clinic as well as potential strategies to overcome these challenges.">
            <meta name="dc.subject" content="Integrin, Cancer Therapy, Cell Signalling, ">
            <meta name="dc.creator" content="Longmate, Whitney">
            <meta name="dc.creator" content="DiPersio, C Michael">
            <meta name="dc.date" content="2017/08/31">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.11877.1">
            <meta name="dc.source" content="F1000Research 2017 6:1612">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="Integrin ">
            <meta name="prism.keyword" content=" Cancer Therapy ">
            <meta name="prism.keyword" content=" Cell Signalling ">
            <meta name="prism.keyword" content=" ">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2017/08/31">
            <meta name="prism.volume" content="6">
            <meta name="prism.number" content="1612">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.11877.1">
            <meta name="prism.url" content="https://f1000research.com/articles/6-1612">
            <meta name="citation_title" content="Beyond adhesion:&amp;nbsp;emerging roles for integrins in control of the tumor microenvironment">
            <meta name="citation_abstract" content="While integrins were originally discovered as cell adhesion receptors, recent studies have reinforced the concept that integrins have central roles in cancer that extend far beyond controlling cell adhesion and migration. Indeed, as transmembrane cell surface receptors that occupy a critical position at the interface of cellular and extracellular interactions and are capable of both &ldquo;inside-out&rdquo; and &ldquo;outside-in&rdquo; signaling, integrins are uniquely poised to regulate the cell&rsquo;s ability to promote, sense, and react to changes in the tumor microenvironment. Moreover, integrins are present on all cell types in the tumor microenvironment, and they have important roles in regulating intercellular communication. Decades of promising pre-clinical studies have implicated certain integrins as attractive therapeutic targets in the cancer clinic. Nevertheless, results of the few clinical trials that target integrins in cancer have thus far been disappointing. Importantly, these clinical failures likely reflect the emerging complexity of individual and combinatorial integrin function within both tumor cells and other cell types of the tumor microenvironment, together with a need to explore integrin-targeting agents not just as monotherapies but also as adjuvants to more conventional radiotherapies or chemotherapies. In this review, we will examine recent advances toward understanding how integrins regulate cancer progression, including their roles in intercellular communication and modulation of the tumor microenvironment. Additionally, we will discuss factors that underlie the limited efficacy of current efforts to target integrins in the cancer clinic as well as potential strategies to overcome these challenges.">
            <meta name="citation_description" content="While integrins were originally discovered as cell adhesion receptors, recent studies have reinforced the concept that integrins have central roles in cancer that extend far beyond controlling cell adhesion and migration. Indeed, as transmembrane cell surface receptors that occupy a critical position at the interface of cellular and extracellular interactions and are capable of both &ldquo;inside-out&rdquo; and &ldquo;outside-in&rdquo; signaling, integrins are uniquely poised to regulate the cell&rsquo;s ability to promote, sense, and react to changes in the tumor microenvironment. Moreover, integrins are present on all cell types in the tumor microenvironment, and they have important roles in regulating intercellular communication. Decades of promising pre-clinical studies have implicated certain integrins as attractive therapeutic targets in the cancer clinic. Nevertheless, results of the few clinical trials that target integrins in cancer have thus far been disappointing. Importantly, these clinical failures likely reflect the emerging complexity of individual and combinatorial integrin function within both tumor cells and other cell types of the tumor microenvironment, together with a need to explore integrin-targeting agents not just as monotherapies but also as adjuvants to more conventional radiotherapies or chemotherapies. In this review, we will examine recent advances toward understanding how integrins regulate cancer progression, including their roles in intercellular communication and modulation of the tumor microenvironment. Additionally, we will discuss factors that underlie the limited efficacy of current efforts to target integrins in the cancer clinic as well as potential strategies to overcome these challenges.">
            <meta name="citation_keywords" content="Integrin, Cancer Therapy, Cell Signalling, ">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Whitney Longmate">
            <meta name="citation_author_institution" content="Department of Regenerative and Cancer Cell Biology, Albany Medical College, Albany, New York, USA">
            <meta name="citation_author" content="C Michael DiPersio">
            <meta name="citation_author_institution" content="Department of Surgery, Albany Medical College, Albany , New York, USA">
            <meta name="citation_author_institution" content="Department of Regenerative and Cancer Cell Biology, Albany Medical College, Albany, New York, USA">
            <meta name="citation_publication_date" content="2017/08/31">
            <meta name="citation_volume" content="6">
            <meta name="citation_publication_number" content="1612">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.11877.1">
            <meta name="citation_firstpage" content="1612">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/6-1612/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/6-1612.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=12834 /> <input type=hidden id=articleId name=articleId value=11877 /> <input type=hidden id=xmlUrl value="/articles/6-1612/v1/xml"/> <input type=hidden id=xmlFileName value="-6-1612-v1.xml"> <input type=hidden id=article_uuid value=199d194a-69bb-4c20-bb56-c5112e8f13c4 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Beyond adhesion:&nbsp;emerging roles for integrins in control of the tumor microenvironment"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.11877.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.11877.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/6-1612"
  },
  "headline": "Beyond adhesion:Â emerging roles for integrins in control of the tumor microenvironment",
  "datePublished": "2017-08-31T09:20:00",
  "dateModified": "2017-08-31T09:20:00",
  "author": [
    {
      "@type": "Person",
      "name": "Whitney Longmate"
    },    {
      "@type": "Person",
      "name": "C Michael DiPersio"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "While integrins were originally discovered as cell adhesion receptors, recent studies have reinforced the concept that integrins have central roles in cancer that extend far beyond controlling cell adhesion and migration. Indeed, as transmembrane cell surface receptors that occupy a critical position at the interface of cellular and extracellular interactions and are capable of both &ldquo;inside-out&rdquo; and &ldquo;outside-in&rdquo; signaling, integrins are uniquely poised to regulate the cell&rsquo;s ability to promote, sense, and react to changes in the tumor microenvironment. Moreover, integrins are present on all cell types in the tumor microenvironment, and they have important roles in regulating intercellular communication. Decades of promising pre-clinical studies have implicated certain integrins as attractive therapeutic targets in the cancer clinic. Nevertheless, results of the few clinical trials that target integrins in cancer have thus far been disappointing. Importantly, these clinical failures likely reflect the emerging complexity of individual and combinatorial integrin function within both tumor cells and other cell types of the tumor microenvironment, together with a need to explore integrin-targeting agents not just as monotherapies but also as adjuvants to more conventional radiotherapies or chemotherapies. In this review, we will examine recent advances toward understanding how integrins regulate cancer progression, including their roles in intercellular communication and modulation of the tumor microenvironment. Additionally, we will discuss factors that underlie the limited efficacy of current efforts to target integrins in the cancer clinic as well as potential strategies to overcome these challenges."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/6-1612.html",
            "name": "Beyond adhesion:emerging roles for integrins in control of the tumor..."
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Beyond adhesion:emerging roles for integrins in control of the tumor... </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=12834 data-id=11877 data-downloads="" data-views="" data-scholar="10.12688/f1000research.11877.1" data-recommended="" data-doi="10.12688/f1000research.11877.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/6-1612/v1/pdf?article_uuid=199d194a-69bb-4c20-bb56-c5112e8f13c4" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-11877-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-11877-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-11877-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Longmate W and DiPersio CM. Beyond adhesion:&nbsp;emerging roles for integrins in control of the tumor microenvironment [version 1; peer review: 4 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1612 (<a class=new-orange href="https://doi.org/10.12688/f1000research.11877.1" target=_blank>https://doi.org/10.12688/f1000research.11877.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-11877-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=11877 id=track-article-signin-11877 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/11877?target=/articles/6-1612.html">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=12834 /> <input name=articleId type=hidden value=11877 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Beyond adhesion:&nbsp;emerging roles for integrins in control of the tumor microenvironment</h1><span class=other-info> [version 1; peer review: 4 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Whitney Longmate<sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:dipersm@mail.amc.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>C Michael DiPersio</span></a><a href="https://orcid.org/0000-0001-9366-230X" target=_blank id=author-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-9366-230X</div><sup>1,2</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Whitney Longmate<sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:dipersm@mail.amc.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>C Michael DiPersio</span></a><a href="http://orcid.org/0000-0001-9366-230X" target=_blank id=mauthor-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-9366-230X</div><sup>1,2</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 31 Aug 2017 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.11877.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Regenerative and Cancer Cell Biology, Albany Medical College, Albany, New York, USA<br/> <sup>2</sup> Department of Surgery, Albany Medical College, Albany , New York, USA<br/> <p> <div class=margin-bottom> Whitney Longmate <br/> <span>Roles: </span> Conceptualization, Writing â Original Draft Preparation, Writing â Review & Editing </div> <div class=margin-bottom> C Michael DiPersio <br/> <span>Roles: </span> Conceptualization, Funding Acquisition, Writing â Original Draft Preparation, Writing â Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=25475-25541></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=25474-25543></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=25476-25542></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=25477-25540></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> While integrins were originally discovered as cell adhesion receptors, recent studies have reinforced the concept that integrins have central roles in cancer that extend far beyond controlling cell adhesion and migration. Indeed, as transmembrane cell surface receptors that occupy a critical position at the interface of cellular and extracellular interactions and are capable of both âinside-outâ and âoutside-inâ signaling, integrins are uniquely poised to regulate the cellâs ability to promote, sense, and react to changes in the tumor microenvironment. Moreover, integrins are present on all cell types in the tumor microenvironment, and they have important roles in regulating intercellular communication. Decades of promising pre-clinical studies have implicated certain integrins as attractive therapeutic targets in the cancer clinic. Nevertheless, results of the few clinical trials that target integrins in cancer have thus far been disappointing. Importantly, these clinical failures likely reflect the emerging complexity of individual and combinatorial integrin function within both tumor cells and other cell types of the tumor microenvironment, together with a need to explore integrin-targeting agents not just as monotherapies but also as adjuvants to more conventional radiotherapies or chemotherapies. In this review, we will examine recent advances toward understanding how integrins regulate cancer progression, including their roles in intercellular communication and modulation of the tumor microenvironment. Additionally, we will discuss factors that underlie the limited efficacy of current efforts to target integrins in the cancer clinic as well as potential strategies to overcome these challenges. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> Integrin, Cancer Therapy, Cell Signalling, </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> C Michael DiPersio (<a href="mailto:dipersm@mail.amc.edu">dipersm@mail.amc.edu</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> C Michael DiPersio </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> The authors declare that they have no competing interests. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> We are supported by National Institutes of Health (R01CA129637, R01AR063778)<br> <br/> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; Â© 2017 Longmate W and DiPersio CM. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Longmate W and DiPersio CM. Beyond adhesion:&nbsp;emerging roles for integrins in control of the tumor microenvironment [version 1; peer review: 4 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1612 (<a href="https://doi.org/10.12688/f1000research.11877.1" target=_blank>https://doi.org/10.12688/f1000research.11877.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 31 Aug 2017, <b>6</b>(F1000 Faculty Rev):1612 (<a href="https://doi.org/10.12688/f1000research.11877.1" target=_blank>https://doi.org/10.12688/f1000research.11877.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 31 Aug 2017, <b>6</b>(F1000 Faculty Rev):1612 (<a href="https://doi.org/10.12688/f1000research.11877.1" target=_blank>https://doi.org/10.12688/f1000research.11877.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d36060e170>The integrin family of cell adhesion receptors</h2><p class="" id=d36060e173>Integrins are the major receptors on the cell surface for adhesion to the extracellular matrix (ECM)<sup><a href="#ref-1">1</a></sup>. All members of the integrin family are heterodimeric, transmembrane glycoproteins that consist of an Î± and a Î² subunit, each with a cytoplasmic domain, a single-pass transmembrane domain, and a large extracellular domain. The dimerization of 18 Î± subunits and 8 Î² subunits in limited combinations leads to the formation of 24 different integrin pairs with distinct and often overlapping ligand-binding specificities. As a group, integrins interact with a plethora of ECM proteins, to which they bind via their extracellular domains<sup><a href="#ref-1">1</a></sup>. Simultaneously, integrins interact with cytoskeletal proteins via their cytoplasmic domains to mediate a physical, transmembrane linkage of the ECM to the cytoskeleton, which is critical for controlling cell shape, polarization, and motility<sup><a href="#ref-1">1</a>â<a href="#ref-5">5</a></sup>.</p><p class="" id=d36060e191>It has long been known that integrins can also interact directly or indirectly with a wide variety of signaling effectors, thereby functioning as conduits of bidirectional signal transduction across the cell membrane<sup><a href="#ref-1">1</a>,<a href="#ref-2">2</a>,<a href="#ref-6">6</a>,<a href="#ref-7">7</a></sup>. Indeed, integrins can regulate intracellular pathways in response to ECM binding or other extracellular cues (i.e. âoutside-inâ signaling) while cytoplasmic interactions can regulate the activation state of an integrin to alter its affinity for extracellular ligands (i.e. âinside-outâ signaling)<sup><a href="#ref-1">1</a>,<a href="#ref-6">6</a>,<a href="#ref-8">8</a></sup>. Such integrin-mediated signal transduction controls a wide variety of cell functions that are important for both normal and pathological processes, including survival, proliferation, migration, ECM remodeling, and gene expression<sup><a href="#ref-1">1</a>,<a href="#ref-3">3</a>,<a href="#ref-6">6</a></sup>.</p><p class="" id=d36060e227>Integrins play critical roles in cancer progression, where they are expressed on the surfaces of both tumor cells and all other cell types present in the tumor microenvironment (TME). From within these distinct cellular compartments, integrins regulate functions of both tumor cells and stromal cells that promote tumor growth and malignant progression, including the above-mentioned cell-autonomous functions, as well as communication between different cell types of the TME (for reviews, see <a href="#ref-9">9</a>â<a href="#ref-14">14</a>). Thus, as bidirectional signaling receptors that regulate both cell-mediated changes to the microenvironment and cellular responses to those changes, integrins are attractive targets for therapeutic strategies against cancer. Indeed, the general concept of targeting integrin function to treat cancer or other diseases is already well established<sup><a href="#ref-10">10</a>,<a href="#ref-11">11</a>,<a href="#ref-15">15</a>,<a href="#ref-16">16</a></sup>. Here, we will briefly examine the current state of integrin-targeting cancer therapeutics, as well as limitations and knowledge gaps in the field that must be overcome to better exploit integrins as efficacious cancer targets. In particular, we will consider recent advances in understanding the complex roles that integrins play in modulating the TME and how this knowledge may impact the development of strategies to target integrins in the clinic, either as monotherapies or as adjuvants to conventional radiotherapies or chemotherapies.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d36060e252>Pro-tumorigenic integrin signaling in cancer cells</h2><p class="" id=d36060e255>Generally, integrin-mediated signal transduction occurs through direct or indirect interaction of the integrin cytoplasmic domain with cytoplasmic signaling effectors, which in some cases may be aided through lateral interactions with other integrin-associated cell surface proteins such as tetraspanins, caveolin, or urokinase-type plasminogen activator receptor (uPAR)<sup><a href="#ref-11">11</a>,<a href="#ref-17">17</a>â<a href="#ref-19">19</a></sup>. It has long been known that various intracellular signaling effectors can propagate outside-in integrin signaling, as reviewed in detail elsewhere<sup><a href="#ref-6">6</a></sup>. Among the best-studied integrin-mediated signaling effectors in cancer cells are the non-receptor tyrosine kinases focal adhesion kinase (FAK) and Src. FAK and Src are both elevated in solid tumors of many origins, including breast, epidermal, and colon cancers, where they contribute to tumor growth and malignancy<sup><a href="#ref-20">20</a>,<a href="#ref-21">21</a></sup>. Following integrin-mediated cell adhesion, FAK is activated by an autophosphorylation event on Y397, which generates a high-affinity binding site for the SH2 domain of Src. Once bound, Src mediates the phosphorylation of additional tyrosine residues of FAK, creating binding sites for other signaling and adaptor molecules. The activated FAK/Src scaffold thereby links integrins to downstream signaling effectors such as the Rac1 GTPase or the mitogen-activated protein kinases (MAPKs, i.e. ERK1/2, JNK, or p38).</p><p class="" id=d36060e279>Such signaling pathway activation can augment tumor cell migration, proliferation, survival, and gene expression, thus contributing to tumor growth and metastasis and implicating these pathways as potential therapeutic targets<sup><a href="#ref-22">22</a>,<a href="#ref-23">23</a></sup>. Interestingly, results of studies in breast and squamous cell carcinoma models suggest that integrins, possibly through FAK signaling pathways, promote tumorigenesis by maintaining the pool of slow-cycling stem cells that are the primary targets of oncogenic transformation<sup><a href="#ref-24">24</a>,<a href="#ref-25">25</a></sup>. Importantly, integrin signaling (in some cases through FAK) has been shown to mediate resistance to conventional therapies such as radiation and chemotherapy<sup><a href="#ref-26">26</a>â<a href="#ref-30">30</a></sup>, indicating that the inhibition of integrins may prove to be most beneficial in the adjuvant setting to render other therapies more effective (as reviewed in <a href="#ref-30">30</a>). On the other hand, the stimulation of integrin signaling using agonists has also been shown to improve the response of melanoma to chemotherapy, suggesting that in some cancers the activation, rather than inhibition, of certain integrins may be beneficial, as reviewed elsewhere<sup><a href="#ref-31">31</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d36060e313>Roles for integrins in the regulation of the tumor microenvironment</h2><p class="" id=d36060e316>It is now well accepted that transformed cells, in and of themselves, are not sufficient to generate appreciable tumors with metastatic potential. Rather, cancer development additionally requires a permissive TME, and recent work in the field of cancer biology has begun to focus more on non-tumor cell components of the stroma as drivers of malignant progression (for reviews on this topic, see <a href="#ref-32">32</a>â<a href="#ref-34">34</a>). As bidirectional signal transducers that are expressed on all cell types within the TME, integrins have emerged as regulators of tissue remodeling and intercellular communication between different cell types that drive tumor-supporting features of the tumor niche. In the following sections, we will focus on the roles that integrins play in modulating the TME through control over matrix remodeling and paracrine communication between distinct cell types. We will also discuss the importance of considering the complexity of these roles when attempting to circumvent the challenges associated with integrin-targeting therapies in the cancer clinic.</p><div class=section><a name=d36060e325 class=n-a></a><h3 class=section-title>Integrin regulation of tumor cell invasion and metastasis</h3><p class="" id=d36060e330>The journey of a cancer cell from the primary tumor to a distant metastatic site is an arduous one. To survive this journey, cancer cells must be able to disassociate from the primary tumor, invade adjacent stroma, intravasate the vasculature (either blood or lymph), survive circulation, then extravasate from the vasculature into a hospitable secondary site. Each step of this metastatic process selects for those tumor cells that have acquired genetic and/or epigenetic traits that allow them to survive, grow, and invade in the face of a dynamic microenvironment and to degrade or remodel basement membranes/ECM along the way<sup><a href="#ref-35">35</a></sup>.</p><p class="" id=d36060e337>Integrins play vital roles in cancer metastasis during every leg of the metastatic cascade<sup><a href="#ref-36">36</a>,<a href="#ref-37">37</a></sup>. Indeed, integrins are critical in mediating adhesion dynamics and migration during metastasis through their ability to regulate both physical interactions with the ECM and actin cytoskeletal dynamics<sup><a href="#ref-3">3</a>â<a href="#ref-5">5</a></sup>. Certainly, roles for integrins extend well beyond cell adhesion and migration in their capacity to stimulate intracellular signaling pathways that promote proliferation and survival<sup><a href="#ref-6">6</a>,<a href="#ref-38">38</a></sup>. Consistently, the upregulation or persistence of certain integrins has been generally linked to tumor invasiveness<sup><a href="#ref-9">9</a>,<a href="#ref-12">12</a></sup>. For example, the expression on certain cancer cells of a number of integrin subunits, including Î±3, Î±5, Î±6, Î±v, Î²1, Î²3, and Î²4, has been linked to invasive and metastatic potential<sup><a href="#ref-39">39</a>â<a href="#ref-42">42</a></sup>.</p><p class="" id=d36060e375>With regard to the metastatic spread of cancer, the ability of integrins to control cell adhesion and migration alone is insufficient to drive invasion/metastasis, since an intact basement membrane and stromal ECM provides a physical barrier that precludes a normal cellâs ability to invade local and metastatic sites. Thus, a critically important function of integrins is their additional ability to regulate matrix organization and remodeling through both proteolytic and non-proteolytic mechanisms<sup><a href="#ref-12">12</a>,<a href="#ref-43">43</a></sup>. Indeed, their dual roles in modulating both cell migration and ECM remodeling makes them astute mediators of invasion and metastasis and further implicates them as viable targets for therapeutic intervention.</p><p class="" id=d36060e385>Numerous studies have shown that integrins can promote cell invasion through controlling the expression and/or proteolytic function of matrix metalloproteases (MMPs) and other extracellular proteases that directly degrade ECM proteins, as reviewed extensively elsewhere<sup><a href="#ref-12">12</a>,<a href="#ref-44">44</a></sup>. Additionally, it is important to keep in mind that integrin-mediated modulation of MMPs and other matrix-modifying enzymes can impact tumorigenesis through the release of ECM-bound reservoirs of stored growth factors into the TME<sup><a href="#ref-45">45</a>,<a href="#ref-46">46</a></sup>. In these ways, the impact of integrin-dependent protease expression/function can have profound effects on cancer progression, including by mediating intercellular communication between cells in the TME via proteolytic activation of growth factor signaling<sup><a href="#ref-47">47</a>â<a href="#ref-49">49</a></sup>.</p></div><div class=section><a name=d36060e410 class=n-a></a><h3 class=section-title>Integrin regulation of tumor angiogenesis</h3><p class="" id=d36060e415>Since intratumoral vessel generation is essential for appreciable tumor growth, many anti-cancer therapeutics have focused on the inhibition of endothelial cell functions required for angiogenesis rather than directly targeting tumor cells themselves<sup><a href="#ref-50">50</a>,<a href="#ref-51">51</a></sup>. It is well documented that several endothelial integrins, such as certain Î±v integrins and Î±5Î²1, have complex roles in promoting tumor angiogenesis through the regulation of endothelial cell migration and proliferation<sup><a href="#ref-52">52</a>â<a href="#ref-54">54</a></sup> and that simultaneous inhibition of both Î±vÎ²3 and Î±5Î²1 may be required for potent anti-angiogenic effects in some cases<sup><a href="#ref-55">55</a></sup>. Interestingly, another recent study showed that endothelial-specific deletion in mice of key RGD-binding integrins (i.e. Î±5Î²1 and Î±vÎ²3/Î²5) failed to reduce tumor angiogenesis, indicating compensatory involvement of other integrins and illustrating the potential importance of targeting multiple integrins at once to inhibit tumor angiogenesis<sup><a href="#ref-56">56</a></sup>. Indeed, pro-angiogenic roles for the collagen-binding integrins Î±1Î²1 and Î±2Î²1 have been described<sup><a href="#ref-57">57</a></sup>. Additionally, integrin Î±4Î²1 and its ligand, vascular cell adhesion molecule-1 (VCAM-1), have been demonstrated to be important in vessel formation in both tumor and non-tumor settings<sup><a href="#ref-58">58</a>,<a href="#ref-59">59</a></sup>. Other potentially important receptors on endothelial cells include the laminin-binding integrins Î±3Î²1, Î±6Î²1, and Î±6Î²4<sup><a href="#ref-60">60</a>,<a href="#ref-61">61</a></sup>; however, their roles in angiogenesis are less well explored. Results of genetic studies indicate that while endothelial Î²4 promotes tumor angiogenesis<sup><a href="#ref-62">62</a></sup>, the Î±6 and Î±3 integrin subunits have suppressive roles in tumor angiogenesis<sup><a href="#ref-63">63</a>,<a href="#ref-64">64</a></sup>. Collectively, these findings may reflect opposite roles for Î±6Î²1 and Î±6Î²4 in tumor angiogenesis<sup><a href="#ref-62">62</a>,<a href="#ref-63">63</a></sup>, emphasizing the importance of delineating between integrin heterodimers that share a subunit. Clearly, elucidating the complex roles of endothelial integrins in the regulation of tumor angiogenesis will require further studies that take into consideration the complex interplay between the various integrins that are expressed by the vasculature.</p><p class="" id=d36060e477>Some integrins on tumor cells can promote angiogenesis in a paracrine fashion by inducing the secretion of soluble factors that stimulate endothelial cells, emphasizing the importance of targeting integrins within the appropriate cellular compartment of the tumor. For example, we and others have shown that integrin Î±3Î²1 in breast cancer cells can stimulate the expression of MMP-9<sup><a href="#ref-65">65</a></sup> and Cox-2<sup><a href="#ref-66">66</a></sup>, indicating a role for this integrin in generating pro-angiogenic paracrine signals from tumor cells to endothelial cells. This function reflects a similar role for Î±3Î²1 in wound epidermis, where it regulates the expression of pro-angiogenic factors that induce the paracrine stimulation of angiogenesis<sup><a href="#ref-67">67</a></sup>. Similarly, integrin Î±6Î²4 has been shown to enhance the expression of vascular endothelial growth factor in breast carcinoma cells, impacting not only angiogenesis but also tumor cell survival<sup><a href="#ref-68">68</a></sup>. Paradoxically, as mentioned above, the expression of Î±6 or Î±3 on vascular endothelial cells has been associated with the repression of pathological angiogenesis<sup><a href="#ref-63">63</a>,<a href="#ref-64">64</a></sup>, illustrating the important point that roles for specific integrins are dependent on cellular context and that these roles are not necessarily the same across distinct cellular compartments. Additionally, our recent study demonstrated that integrin Î±9Î²1 in the epidermis can inhibit Î±3Î²1-dependent, paracrine stimulation of wound angiogenesis<sup><a href="#ref-69">69</a></sup>, indicating that cross-suppression/transdominant inhibition amongst integrins<sup><a href="#ref-70">70</a>â<a href="#ref-72">72</a></sup> adds another level of complexity to their roles in regulating angiogenesis that must be considered when developing integrin-targeting strategies.</p></div><div class=section><a name=d36060e516 class=n-a></a><h3 class=section-title>Integrin regulation of intercellular communication within the TME</h3><p class="" id=d36060e521>While it has been well established for some time that a pro-angiogenic microenvironment is critical for cancer progression, contributions from other stromal components of the TME had been underappreciated until more recently. For example, tumor-associated fibroblasts (TAFs)/cancer-associated fibroblasts (CAFs) and tumor-associated macrophages (TAMs) had been viewed largely as passive stromal constituents or bystanders to the ravaging effects of tumorigenesis and metastasis. On the contrary, critical roles for these tumor-associated stromal cells in cancer progression are now beginning to be understood<sup><a href="#ref-32">32</a>,<a href="#ref-34">34</a>,<a href="#ref-73">73</a>,<a href="#ref-74">74</a></sup>. In the preceding section, we discussed recent evidence that certain integrins (e.g. Î±3Î²1) can control paracrine communication from tumor/epithelial cells to endothelial cells of the vasculature. It seems likely that such roles for integrins in intercellular communication will extend to other tumor-associated stromal cells that contribute to a tumor-permissive microenvironment.</p><p class="" id=d36060e537>It is now well known that TAFs/CAFs promote invasion and metastasis in several cancer types, owing in large part to their myofibroblast-like traits that generate a stiff ECM<sup><a href="#ref-75">75</a>â<a href="#ref-77">77</a></sup>. There is evidence that some integrins can contribute to the generation of stiff ECM. For example, integrin Î±2Î²1 ligation by collagen has been shown to regulate lysyl oxidase expression in cardiac fibroblasts<sup><a href="#ref-78">78</a></sup>, raising the possibility that integrins on TAFs have similar roles in promoting collagen crosslinking and ECM stiffness. Furthermore, as mediators of outside-in signal transduction, integrins play important roles in mechanosensing in response to ECM stiffness<sup><a href="#ref-79">79</a></sup>. Indeed, matrix stiffening has been demonstrated to promote tumorigenesis, at least in part, through the activation of integrin signaling<sup><a href="#ref-80">80</a></sup>. This potential for integrins to both promote and respond to ECM stiffening is consistent with their central role in the âdynamic reciprocityâ that has long been known to exist between cells and the ECM<sup><a href="#ref-81">81</a></sup>.</p><p class="" id=d36060e563>While ECM stiffness is certainly important in tumorigenesis<sup><a href="#ref-82">82</a></sup>, it has become apparent that the roles of TAFs extend beyond the promotion of a desmoplastic TME to include the generation of paracrine signals to other cell types. In some cases, the response of the target cell to signals generated by TAFs (or other mesenchymal cells of the stroma) is mediated by integrins. For example, it was recently demonstrated in a gastric cancer model that activation of CXCL12/CXCR4 signaling in TAFs promotes the clustering of Î²1 integrins on tumor cells, thereby activating FAK signaling and promoting invasion<sup><a href="#ref-83">83</a></sup>. Similarly, Î²1 integrins were essential in tamoxifen-resistant breast cancer cells for migration and epithelialâmesenchymal transition that was induced by signals from TAFs<sup><a href="#ref-84">84</a></sup>. In another example, CD151 (a tetraspanin that complexes with certain laminin-binding integrins) was recently found to mediate pro-tumorigenic responses of prostate cancer cells to signals from tumor-associated osteoblasts<sup><a href="#ref-85">85</a></sup>. Additionally, some tumor cell integrins may activate pro-invasive proteolytic cascades through interactions with stromal cells. For example, the interaction of integrin Î±6Î²1 expressed on pancreatic cancer cells with uPAR expressed on stromal fibroblasts was linked with activation in the latter cells of the uPARâuPAâMMP-2 proteolytic cascade, thereby aiding in tumor progression<sup><a href="#ref-86">86</a></sup>.</p><p class="" id=d36060e586>TAMs have also been linked to tumor progression in particular through their ability to promote tumor angiogenesis and invasion, although the molecular underpinnings of this link have just begun to be elucidated<sup><a href="#ref-87">87</a>â<a href="#ref-89">89</a></sup>. Importantly, some recent studies have implicated integrins in regulating the ability of TAMs to promote tumor progression. For example, an osteopontin-rich matrix activates TAMs in a melanoma model through ligation of integrin Î±9Î²1, leading to prostaglandin E2 production by TAMs that then stimulates the migration of both endothelial and cancer cells<sup><a href="#ref-90">90</a></sup>. Similarly, the ECM protein periostin, secreted by glioblastoma stem cells, may promote TAM recruitment to tumors via activation of Î±vÎ²3 on the latter cells<sup><a href="#ref-91">91</a></sup>. Additionally, integrin Î²2 interactions have been implicated in TAM-driven dissemination of tumor cells in an <i>in vitro</i> microfluidic model of lung adenocarcinoma<sup><a href="#ref-92">92</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d36060e615>Integrins as targets for anti-cancer therapy</h2><p class="" id=d36060e618>Integrins have several characteristics that make them attractive anti-cancer targets. First, they are generally important for mediating numerous cellular functions in all stages of cancer progression, including tumor cell proliferation, survival, angiogenesis, invasion, and metastasis<sup><a href="#ref-9">9</a>,<a href="#ref-10">10</a>,<a href="#ref-38">38</a></sup>. Additionally, as cell surface receptors, the integrins are relatively accessible by targeting agents. Finally, the broad impact on cell function of integrin-mediated signaling indicates that targeting a single integrin, or group of integrins, might generate a combinatorial and potentially potent effect. Unfortunately, these same broad functions of integrins, which occur in both normal cells and tumor cells, also make them difficult to exploit as targets in the clinic. The remainder of this review will discuss integrin-targeting strategies and the associated challenges as we move forward in exploiting these targets more efficaciously in the cancer clinic, including their development as adjuvant targets in currently used therapies.</p><div class=section><a name=d36060e631 class=n-a></a><h3 class=section-title>Clinical limitations of integrin-targeting anti-cancer therapeutics</h3><p class="" id=d36060e636>From around the late 1990s to date, pre-clinical studies performed in a wide variety of cancer models have demonstrated that blockade or suppression of certain integrins can inhibit tumor growth or metastasis<sup><a href="#ref-9">9</a>,<a href="#ref-10">10</a>,<a href="#ref-38">38</a>,<a href="#ref-93">93</a></sup>. Outside the cancer clinic, a number of integrin-based therapeutics have progressed to phase II or phase III clinical trials, and some have had significant benefits for patients suffering from a number of disorders, including multiple sclerosis, thrombotic complications, and inflammatory bowel disease (IBD) (for excellent reviews on this topic, see <a href="#ref-16">16</a>,<a href="#ref-31">31</a>,<a href="#ref-94">94</a>). As one example, vedolizumab, an antibody against integrin Î±4Î²7, is approved for use in the United States, Canada, and Europe for patients with either subtype of IBD (ulcerative colitis or Crohnâs disease), both of which are potential precursors to gastrointestinal malignancies<sup><a href="#ref-94">94</a>,<a href="#ref-95">95</a></sup>. With regard to cancer, the concept of targeting integrins in the clinic using small molecule integrin antagonists (SMIAs) was realized when the integrin-blocking RGD mimetic Cilengitide entered clinical trials after performing well pre-clinically<sup><a href="#ref-16">16</a></sup>. Unfortunately, the transition of Cilengitide to the cancer clinic as a monotherapy has been met with little success<sup><a href="#ref-96">96</a>,<a href="#ref-97">97</a></sup>, which may be attributable in large part to several limitations. First, RGD mimetics target only the subgroup of integrins that bind RGD-containing ligands (e.g. fibronectin, tenascin, and vitronectin)<sup><a href="#ref-1">1</a></sup> while failing to block other potentially important integrins that bind non-RGD ligands such as laminins. Indeed, the laminin-binding integrins remain unexplored as clinical targets despite abundant pre-clinical evidence that supports their participation in tumor growth and metastasis<sup><a href="#ref-11">11</a>,<a href="#ref-15">15</a>,<a href="#ref-24">24</a>,<a href="#ref-66">66</a>,<a href="#ref-68">68</a>,<a href="#ref-98">98</a>â<a href="#ref-103">103</a></sup>. Additionally, as discussed more below, integrin-targeting agents may prove to be most effective in the cancer clinic as adjuvant therapies alongside more conventional chemotherapy or radiation treatments<sup><a href="#ref-30">30</a>,<a href="#ref-104">104</a>â<a href="#ref-106">106</a></sup>.</p><p class="" id=d36060e717>Importantly, while Cilengitide was conceptualized to target RGD-binding integrins on endothelial cells to inhibit tumor angiogenesis, perhaps through abrogation of the FAK/Src/AKT pathway<sup><a href="#ref-10">10</a>,<a href="#ref-107">107</a></sup>, this approach is complicated by the presence of these integrins on additional cell types within the TME. For example, a recent study in a glioblastoma multiforme model showed that treatment with an RGD peptide also inhibits Î±vÎ²3 on TAMs, restricting their recruitment to the TME<sup><a href="#ref-91">91</a></sup>. Accordingly, moving forward it will be important to consider the potential effects of integrin-targeting agents on various cells within the tumor milieu as a whole. This approach is especially important considering that integrin expression profiles show overlap between distinct cell types and that integrins play important roles in paracrine crosstalk between different cells in the TME (discussed above).</p><p class="" id=d36060e731>An additional challenge is the necessity to create more directed therapeutic strategies that target key integrins within the appropriate cellular compartment(s) of the tumor. For example, while several current strategies rest on the premise of targeting endothelial cells to suppress tumor angiogenesis, other strategies that target integrins on tumor cells, or other stromal cells, remain relatively underexplored from a clinical perspective despite strong pre-clinical evidence to support this approach. Additionally, while many studies of integrin function in cancer have provided strong support for focus on the Î²1 integrins as a group, more attention must be paid to the functional diversity among the 12 distinct Î±Î² heterodimers that comprise the Î²1 integrin subfamily<sup><a href="#ref-1">1</a></sup>. Indeed, it has long been known that individual Î²1 integrins have different expression patterns in many tumors<sup><a href="#ref-108">108</a></sup>, and studies have demonstrated diverse or opposing roles for distinct integrins. For example, Î±2Î²1 is a suppressor of metastasis in breast cancer cells<sup><a href="#ref-109">109</a></sup>, while Î±3Î²1 and Î±6Î²1 are pro-tumorigenic or pro-metastatic in breast cancer<sup><a href="#ref-66">66</a>,<a href="#ref-102">102</a>,<a href="#ref-110">110</a>,<a href="#ref-111">111</a></sup>. Moreover, some integrins may have pro-tumorigenic roles in some cancers but anti-tumorigenic roles in other cancers, as has been shown for Î±3Î²1 in breast or skin versus prostate cancer, respectively<sup><a href="#ref-24">24</a>,<a href="#ref-66">66</a>,<a href="#ref-112">112</a></sup>, indicating that the cancer context matters in terms of predicting the effects of inhibiting a particular integrin. Indeed, there are many additional examples wherein the ability of specific Î²1 integrins to perpetuate hallmarks of malignant progression can vary between different types of cancer, as recently reviewed<sup><a href="#ref-113">113</a></sup>.</p></div><div class=section><a name=d36060e775 class=n-a></a><h3 class=section-title>Minding the microenvironment: the future of integrin-targeting therapies</h3><p class="" id=d36060e780>Despite the successful use of different integrin-targeting agents in pre-clinical cancer models, efforts to translate these findings to the cancer clinic have so far failed. This discordance most likely reflects the increasingly appreciated complexity of the integrin family and the knowledge gaps in the field that must be overcome for effective exploitation of integrins as therapeutic targets. Moreover, as already mentioned, a number of studies have indicated that targeting certain integrins may sensitize cancer cells to radiotherapy or other chemotherapies<sup><a href="#ref-104">104</a>,<a href="#ref-105">105</a>,<a href="#ref-114">114</a></sup>, suggesting that integrin-targeting agents may be most effective in the cancer clinic when administered as adjuvants to supplement more traditional cancer therapeutics.</p><p class="" id=d36060e793>As discussed in the preceding sections, current literature clearly supports critical roles for integrins in cell-mediated modulation of the microenvironment that drives normal tissue remodeling or contributes to pathological tissue remodeling. It is also likely that individual integrins have distinct but collectively critical roles in controlling intercellular communication within the TME based on mounting evidence described above that integrins can regulate paracrine signals that emanate from the epithelium or stroma in normal and pathological tissue states. Therefore, identification of the full spectrum of integrins that is expressed on cells within the TME, as well as improved understanding of the combined roles that different integrins play from within these distinct cell types, will be critical for effective exploitation of integrins as anti-cancer targets.</p><p class="" id=d36060e796>In addition to SMIAs discussed above, there are other integrin-targeting strategies that might eventually be exploited in the cancer clinic. An example is the use of aptamers, which act as RNA ligands that can be used to antagonize the protein targets to which they are directed (for a review on the use of aptamers in targeted therapies, see <a href="#ref-115">115</a>). Interestingly, a recent study demonstrated that an aptamer directed at integrin Î±6Î²4 caused reduced adhesion of PC3 prostate cancer cells to laminin-332<sup><a href="#ref-116">116</a></sup>. Internalization of this aptamer was also demonstrated, suggesting potential utility (i.e. beyond adhesion-blocking) for the delivery of siRNA, microRNA, or toxins to Î±6Î²4-decorated cancer cells<sup><a href="#ref-116">116</a></sup>. Furthermore, an aptamer that targets an epidermal growth factor receptor (EGFR)âintegrin Î±vÎ²3 complex was shown to impair Î±vÎ²3-dependent adhesion, as well as the matrix-induced interaction of the integrin with EGFR, thereby inhibiting growth and vasculogenic mimicry of triple-negative breast cancer cells<sup><a href="#ref-117">117</a></sup>.</p><p class="" id=d36060e814>Another example of integrin-targeting agents that may be clinically useful are the disintegrins, which are a family of small proteins found in snake venom that can target and block the adhesion functions of specific integrins (for a review on disintegrins and their potential use in cancer therapy, see <a href="#ref-118">118</a>). Indeed, therapeutic modulation of integrin signaling through the administration of disintegrins was recently shown to elicit anti-migratory and anti-angiogenic effects in both <i>in vitro</i> and <i>in vivo</i> cancer models<sup><a href="#ref-118">118</a>â<a href="#ref-120">120</a></sup>, indicating potential utility in the clinic.</p><p class="" id=d36060e834>In summary, while numerous studies have identified different integrin-targeting strategies, it is becoming increasingly clear that minding the TME will be critical for their effective implementation in the clinic. Moreover, it is highly likely that integrin-targeting agents will be most effective as part of a multi-combinatorial approach rather than as a monotherapy.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d36060e841>Conclusions</h2><p class="" id=d36060e844>The multifaceted nature of integrin biology is increasingly evident as more and more studies reveal the wide range of both distinct and overlapping roles that integrins play, individually and cooperatively, both in normal tissue remodeling and in pathological processes such as tumor progression and metastasis. When considering integrins as possible anti-cancer targets, the vast functionality of the integrin repertoire present on cancer cells, as well as on cells of the tumor stroma, provides considerable complexity even before considering the additional complexities of a dynamic TME. Indeed, the ever-evolving TME must be better understood, and we must take into account the repertoire of integrins that are expressed by distinct cells within the TME (as well as the availability of ligands for those integrins in the TME) while also keeping in mind that the function of a specific integrin may depend on cellular context. In addition, we must consider the abilities of some integrins to regulate paracrine communication between cells as well as the potential for combinatorial and compensatory functions of different integrins.</p><p class="" id=d36060e847>Despite the challenges raised by these complexities, as a group the integrins remain potentially powerful anti-cancer targets worthy of further investigation and exploitation in the clinic. Whether integrins will be useful as adjuvant targets or targets of monotherapies remains to be seen. In any case, the future of exploiting integrins as anti-cancer targets begins at the bench and will likely require a holistic approach that effectively considers the above-mentioned complexities of integrin biology within the context of an evolving TME. Achieving this goal will require not only the identification of the full spectrum of integrins expressed by both tumor cells and stromal cells within the TME but also the elucidation of how different integrins function coordinately and cooperatively within these cells. Such an approach should facilitate our ability to determine the most effective integrin combinations to target at the most appropriate stages of disease progression.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d36060e854>Abbreviations</h2><p class="" id=d36060e857>CAF, cancer-associated fibroblast; ECM, extracellular matrix; EGFR, epidermal growth factor receptor; FAK, focal adhesion kinase; IBD, inflammatory bowel disease; MAPK, mitogen-activated protein kinase; MMP, matrix metalloprotease; TAF, tumor-associated fibroblast; TAM, tumor-associated macrophage; TME, tumor microenvironment; uPAR, urokinase-type plasminogen activator receptor.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d36060e1 class=n-a></a><h2 class=main-title id=d36375>Competing interests</h2><p class=metadata-entry><a name=d36060e99 class=n-a></a><p id=d36060e101> The authors declare that they have no competing interests.</p></p></div><div class=back-section><a name=d36060e1 class=n-a></a><h2 class=main-title id=d36377>Grant information</h2><p>We are supported by the National Institutes of Health (R01CA129637, R01AR063778).</p><p> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </p></div><div class=back-section><a name=d36060e864 class=n-a></a><h2 class=main-title id=d36060e866>Acknowledgements</h2><p class="" id=d36060e869>The authors are grateful to Dr Sita Subbaram for critical reading of the manuscript and for important insight provided by other colleagues at Albany Medical College as well as members of the DiPersio laboratory. Research in the DiPersio laboratory is supported by NIH grants from NCI to C. M. DiPersio (R01CA129637) and from NIAMS to L. Van De Water and C. M. DiPersio (R01AR063778). We are thankful for the many researchers whose valuable contributions to the field could not be cited owing to space constraints.</p></div><div class=back-section><a name=d36060e873 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d36811>References</h2><div class="section ref-list"><a name=d36060e873 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d36060e880 class=n-a></a>Hynes RO: Integrins: bidirectional, allosteric signaling machines. <i>Cell.</i> 2002; <b>110</b>(6): 673â87. <a target=xrefwindow id=d36060e888 href="http://www.ncbi.nlm.nih.gov/pubmed/12297042">PubMed Abstract </a> | <a target=xrefwindow id=d36060e891 href="http://dx.doi.org/10.1016/S0092-8674(02)00971-6">Publisher Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d36060e900 class=n-a></a>Liu S, Calderwood DA, Ginsberg MH: Integrin cytoplasmic domain-binding proteins. <i>J Cell Sci.</i> 2000; <b>113</b>(Pt 20): 3563â71. <a target=xrefwindow id=d36060e908 href="http://www.ncbi.nlm.nih.gov/pubmed/11017872">PubMed Abstract </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d36060e917 class=n-a></a>Ridley AJ, Schwartz MA, Burridge K, <i> et al.</i>: Cell migration: integrating signals from front to back. <i>Science.</i> 2003; <b>302</b>(5651): 1704â9. <a target=xrefwindow id=d36060e928 href="http://www.ncbi.nlm.nih.gov/pubmed/14657486">PubMed Abstract </a> | <a target=xrefwindow id=d36060e931 href="http://dx.doi.org/10.1126/science.1092053">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d36060e940 class=n-a></a>Litjens SH, de Pereda JM, Sonnenberg A: Current insights into the formation and breakdown of hemidesmosomes. <i>Trends Cell Biol.</i> 2006; <b>16</b>(7): 376â83. <a target=xrefwindow id=d36060e948 href="http://www.ncbi.nlm.nih.gov/pubmed/16757171">PubMed Abstract </a> | <a target=xrefwindow id=d36060e951 href="http://dx.doi.org/10.1016/j.tcb.2006.05.004">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d36060e960 class=n-a></a>Delon I, Brown NH: Integrins and the actin cytoskeleton. <i>Curr Opin Cell Biol.</i> 2007; <b>19</b>(1): 43â50. <a target=xrefwindow id=d36060e968 href="http://www.ncbi.nlm.nih.gov/pubmed/17184985">PubMed Abstract </a> | <a target=xrefwindow id=d36060e971 href="http://dx.doi.org/10.1016/j.ceb.2006.12.013">Publisher Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d36060e981 class=n-a></a>Schwartz MA, Ginsberg MH: Networks and crosstalk: integrin signalling spreads. <i>Nat Cell Biol.</i> 2002; <b>4</b>(4): E65â8. <a target=xrefwindow id=d36060e989 href="http://www.ncbi.nlm.nih.gov/pubmed/11944032">PubMed Abstract </a> | <a target=xrefwindow id=d36060e992 href="http://dx.doi.org/10.1038/ncb0402-e65">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d36060e1001 class=n-a></a>Legate KR, FÃ¤ssler R: Mechanisms that regulate adaptor binding to beta-integrin cytoplasmic tails. <i>J Cell Sci.</i> 2009; <b>122</b>(Pt 2): 187â98. <a target=xrefwindow id=d36060e1009 href="http://www.ncbi.nlm.nih.gov/pubmed/19118211">PubMed Abstract </a> | <a target=xrefwindow id=d36060e1012 href="http://dx.doi.org/10.1242/jcs.041624">Publisher Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d36060e1021 class=n-a></a>Askari JA, Buckley PA, Mould AP, <i> et al.</i>: Linking integrin conformation to function. <i>J Cell Sci.</i> 2009; <b>122</b>(Pt 2): 165â70. <a target=xrefwindow id=d36060e1032 href="http://www.ncbi.nlm.nih.gov/pubmed/19118208">PubMed Abstract </a> | <a target=xrefwindow id=d36060e1035 href="http://dx.doi.org/10.1242/jcs.018556">Publisher Full Text </a> | <a target=xrefwindow id=d36060e1039 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2714414">Free Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d36060e1048 class=n-a></a>Brakebusch C, Bouvard D, Stanchi F, <i> et al.</i>: Integrins in invasive growth. <i>J Clin Invest.</i> 2002; <b>109</b>(8): 999â1006. <a target=xrefwindow id=d36060e1059 href="http://www.ncbi.nlm.nih.gov/pubmed/11956235">PubMed Abstract </a> | <a target=xrefwindow id=d36060e1062 href="http://dx.doi.org/10.1172/JCI15468">Publisher Full Text </a> | <a target=xrefwindow id=d36060e1066 href="http://www.ncbi.nlm.nih.gov/pmc/articles/150953">Free Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d36060e1075 class=n-a></a>Desgrosellier JS, Cheresh DA: Integrins in cancer: biological implications and therapeutic opportunities. <i>Nat Rev Cancer.</i> 2010; <b>10</b>(1): 9â22. <a target=xrefwindow id=d36060e1083 href="http://www.ncbi.nlm.nih.gov/pubmed/20029421">PubMed Abstract </a> | <a target=xrefwindow id=d36060e1086 href="http://dx.doi.org/10.1038/nrc2748">Publisher Full Text </a> | <a target=xrefwindow id=d36060e1089 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4383089">Free Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d36060e1098 class=n-a></a>Stipp CS: Laminin-binding integrins and their tetraspanin partners as potential antimetastatic targets. <i>Expert Rev Mol Med.</i> 2010; <b>12</b>: e3. <a target=xrefwindow id=d36060e1106 href="http://www.ncbi.nlm.nih.gov/pubmed/20078909">PubMed Abstract </a> | <a target=xrefwindow id=d36060e1109 href="http://dx.doi.org/10.1017/S1462399409001355">Publisher Full Text </a> | <a target=xrefwindow id=d36060e1112 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2811424">Free Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d36060e1122 class=n-a></a>Missan DS, DiPersio M: Integrin control of tumor invasion. <i>Crit Rev Eukaryot Gene Expr.</i> 2012; <b>22</b>(4): 309â24. <a target=xrefwindow id=d36060e1130 href="http://www.ncbi.nlm.nih.gov/pubmed/23272801">PubMed Abstract </a> | <a target=xrefwindow id=d36060e1133 href="http://dx.doi.org/10.1615/CritRevEukarGeneExpr.v22.i4.50">Publisher Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d36060e1142 class=n-a></a>BrÃ¼cher BL, Jamall IS: Cell-cell communication in the tumor microenvironment, carcinogenesis, and anticancer treatment. <i>Cell Physiol Biochem.</i> 2014; <b>34</b>(2): 213â43. <a target=xrefwindow id=d36060e1150 href="http://www.ncbi.nlm.nih.gov/pubmed/25034869">PubMed Abstract </a> | <a target=xrefwindow id=d36060e1153 href="http://dx.doi.org/10.1159/000362978">Publisher Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726786878"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d36060e1162 class=n-a></a>Hamidi H, PietilÃ¤ M, Ivaska J: The complexity of integrins in cancer and new scopes for therapeutic targeting. <i>Br J Cancer.</i> 2016; <b>115</b>(9): 1017â23. <a target=xrefwindow id=d36060e1170 href="http://www.ncbi.nlm.nih.gov/pubmed/27685444">PubMed Abstract </a> | <a target=xrefwindow id=d36060e1173 href="http://dx.doi.org/10.1038/bjc.2016.312">Publisher Full Text </a> | <a target=xrefwindow id=d36060e1176 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5117799">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726786878">F1000 Recommendation</a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d36060e1189 class=n-a></a>Subbaram S, Dipersio CM: Integrin Î±3Î²1 as a breast cancer target. <i>Expert Opin Ther Targets.</i> 2011; <b>15</b>(10): 1197â210. <a target=xrefwindow id=d36060e1197 href="http://www.ncbi.nlm.nih.gov/pubmed/21838596">PubMed Abstract </a> | <a target=xrefwindow id=d36060e1200 href="http://dx.doi.org/10.1517/14728222.2011.609557">Publisher Full Text </a> | <a target=xrefwindow id=d36060e1203 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3212412">Free Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d36060e1212 class=n-a></a>Goodman SL, Picard M: Integrins as therapeutic targets. <i>Trends Pharmacol Sci.</i> 2012; <b>33</b>(7): 405â12. <a target=xrefwindow id=d36060e1220 href="http://www.ncbi.nlm.nih.gov/pubmed/22633092">PubMed Abstract </a> | <a target=xrefwindow id=d36060e1223 href="http://dx.doi.org/10.1016/j.tips.2012.04.002">Publisher Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d36060e1232 class=n-a></a>Chapman HA, Wei Y, Simon DI, <i> et al.</i>: Role of urokinase receptor and caveolin in regulation of integrin signaling. <i>Thromb Haemost.</i> 1999; <b>82</b>(2): 291â7. <a target=xrefwindow id=d36060e1243 href="http://www.ncbi.nlm.nih.gov/pubmed/10605716">PubMed Abstract </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d36060e1253 class=n-a></a>Hemler ME: Tetraspanin functions and associated microdomains. <i>Nat Rev Mol Cell Biol.</i> 2005; <b>6</b>(10): 801â11. <a target=xrefwindow id=d36060e1261 href="http://www.ncbi.nlm.nih.gov/pubmed/16314869">PubMed Abstract </a> | <a target=xrefwindow id=d36060e1264 href="http://dx.doi.org/10.1038/nrm1736">Publisher Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d36060e1273 class=n-a></a>Del Pozo MA, Schwartz MA: Rac, membrane heterogeneity, caveolin and regulation of growth by integrins. <i>Trends Cell Biol.</i> 2007; <b>17</b>(5): 246â50. <a target=xrefwindow id=d36060e1281 href="http://www.ncbi.nlm.nih.gov/pubmed/17363257">PubMed Abstract </a> | <a target=xrefwindow id=d36060e1284 href="http://dx.doi.org/10.1016/j.tcb.2007.03.001">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d36060e1293 class=n-a></a>Frame MC: Src in cancer: deregulation and consequences for cell behaviour. <i>Biochim Biophys Acta.</i> 2002; <b>1602</b>(2): 114â30. <a target=xrefwindow id=d36060e1301 href="http://www.ncbi.nlm.nih.gov/pubmed/12020799">PubMed Abstract </a> | <a target=xrefwindow id=d36060e1304 href="http://dx.doi.org/10.1016/S0304-419X(02)00040-9">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d36060e1313 class=n-a></a>Summy JM, Gallick GE: Src family kinases in tumor progression and metastasis. <i>Cancer Metastasis Rev.</i> 2003; <b>22</b>(4): 337â58. <a target=xrefwindow id=d36060e1321 href="http://www.ncbi.nlm.nih.gov/pubmed/12884910">PubMed Abstract </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d36060e1330 class=n-a></a>Playford MP, Schaller MD: The interplay between Src and integrins in normal and tumor biology. <i>Oncogene.</i> 2004; <b>23</b>(48): 7928â46. <a target=xrefwindow id=d36060e1338 href="http://www.ncbi.nlm.nih.gov/pubmed/15489911">PubMed Abstract </a> | <a target=xrefwindow id=d36060e1341 href="http://dx.doi.org/10.1038/sj.onc.1208080">Publisher Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d36060e1350 class=n-a></a>Brunton VG, Frame MC: Src and focal adhesion kinase as therapeutic targets in cancer. <i>Curr Opin Pharmacol.</i> 2008; <b>8</b>(4): 427â32. <a target=xrefwindow id=d36060e1358 href="http://www.ncbi.nlm.nih.gov/pubmed/18625340">PubMed Abstract </a> | <a target=xrefwindow id=d36060e1361 href="http://dx.doi.org/10.1016/j.coph.2008.06.012">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717996672"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d36060e1371 class=n-a></a>Sachs N, Secades P, van Hulst L, <i> et al.</i>: Loss of integrin Î±3 prevents skin tumor formation by promoting epidermal turnover and depletion of slow-cycling cells. <i>Proc Natl Acad Sci U S A.</i> 2012; <b>109</b>(52): 21468â73. <a target=xrefwindow id=d36060e1382 href="http://www.ncbi.nlm.nih.gov/pubmed/23236172">PubMed Abstract </a> | <a target=xrefwindow id=d36060e1385 href="http://dx.doi.org/10.1073/pnas.1204614110">Publisher Full Text </a> | <a target=xrefwindow id=d36060e1389 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3535625">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717996672">F1000 Recommendation</a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d36060e1402 class=n-a></a>Guan JL: Integrin signaling through FAK in the regulation of mammary stem cells and breast cancer. <i>IUBMB Life.</i> 2010; <b>62</b>(4): 268â76. <a target=xrefwindow id=d36060e1410 href="http://www.ncbi.nlm.nih.gov/pubmed/20101634">PubMed Abstract </a> | <a target=xrefwindow id=d36060e1413 href="http://dx.doi.org/10.1002/iub.303">Publisher Full Text </a> | <a target=xrefwindow id=d36060e1416 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2848709">Free Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d36060e1425 class=n-a></a>Mantoni TS, Lunardi S, Al-Assar O, <i> et al.</i>: Pancreatic stellate cells radioprotect pancreatic cancer cells through Î²1-integrin signaling. <i>Cancer Res.</i> 2011; <b>71</b>(10): 3453â8. <a target=xrefwindow id=d36060e1436 href="http://www.ncbi.nlm.nih.gov/pubmed/21558392">PubMed Abstract </a> | <a target=xrefwindow id=d36060e1439 href="http://dx.doi.org/10.1158/0008-5472.CAN-10-1633">Publisher Full Text </a> | <a target=xrefwindow id=d36060e1443 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3097171">Free Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d36060e1452 class=n-a></a>Goel HL, Sayeed A, Breen M, <i> et al.</i>: Î²<sub>1</sub> integrins mediate resistance to ionizing radiation <i>in vivo</i> by inhibiting c-Jun amino terminal kinase 1. <i>J Cell Physiol.</i> 2013; <b>228</b>(7): 1601â9. <a target=xrefwindow id=d36060e1470 href="http://www.ncbi.nlm.nih.gov/pubmed/23359252">PubMed Abstract </a> | <a target=xrefwindow id=d36060e1473 href="http://dx.doi.org/10.1002/jcp.24323">Publisher Full Text </a> | <a target=xrefwindow id=d36060e1476 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3749928">Free Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d36060e1485 class=n-a></a>Eke I, Deuse Y, Hehlgans S, <i> et al.</i>: Î²<sub>1</sub>Integrin/FAK/cortactin signaling is essential for human head and neck cancer resistance to radiotherapy. <i>J Clin Invest.</i> 2012; <b>122</b>(4): 1529â40. <a target=xrefwindow id=d36060e1499 href="http://www.ncbi.nlm.nih.gov/pubmed/22378044">PubMed Abstract </a> | <a target=xrefwindow id=d36060e1503 href="http://dx.doi.org/10.1172/JCI61350">Publisher Full Text </a> | <a target=xrefwindow id=d36060e1506 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3314473">Free Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d36060e1515 class=n-a></a>Ahmed KM, Zhang H, Park CC: NF-ÎºB regulates radioresistance mediated by Î²1-integrin in three-dimensional culture of breast cancer cells. <i>Cancer Res.</i> 2013; <b>73</b>(12): 3737â48. <a target=xrefwindow id=d36060e1523 href="http://www.ncbi.nlm.nih.gov/pubmed/23576567">PubMed Abstract </a> | <a target=xrefwindow id=d36060e1526 href="http://dx.doi.org/10.1158/0008-5472.CAN-12-3537">Publisher Full Text </a> | <a target=xrefwindow id=d36060e1529 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3698967">Free Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727139633"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d36060e1539 class=n-a></a>Dickreuter E, Cordes N: The cancer cell adhesion resistome: mechanisms, targeting and translational approaches. <i>Biol Chem.</i> 2017; <b>398</b>(7): 721â35. <a target=xrefwindow id=d36060e1547 href="http://www.ncbi.nlm.nih.gov/pubmed/28002024">PubMed Abstract </a> | <a target=xrefwindow id=d36060e1550 href="http://dx.doi.org/10.1515/hsz-2016-0326">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727139633">F1000 Recommendation</a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d36060e1563 class=n-a></a>Tolomelli A, Galletti P, Baiula M, <i> et al.</i>: Can Integrin Agonists Have Cards to Play against Cancer? A Literature Survey of Small Molecules Integrin Activators. <i>Cancers (Basel).</i> 2017; <b>9</b>(7): pii: E78. <a target=xrefwindow id=d36060e1574 href="http://www.ncbi.nlm.nih.gov/pubmed/28678151">PubMed Abstract </a> | <a target=xrefwindow id=d36060e1577 href="http://dx.doi.org/10.3390/cancers9070078">Publisher Full Text </a> | <a target=xrefwindow id=d36060e1581 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5532614">Free Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726235766"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d36060e1590 class=n-a></a>Yuan Y, Jiang YC, Sun CK, <i> et al.</i>: Role of the tumor microenvironment in tumor progression and the clinical applications (Review). <i>Oncol Rep.</i> 2016; <b>35</b>(5): 2499â515. <a target=xrefwindow id=d36060e1601 href="http://www.ncbi.nlm.nih.gov/pubmed/26986034">PubMed Abstract </a> | <a target=xrefwindow id=d36060e1604 href="http://dx.doi.org/10.3892/or.2016.4660">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726235766">F1000 Recommendation</a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d36060e1617 class=n-a></a>Zhang J, Liu J: Tumor stroma as targets for cancer therapy. <i>Pharmacol Ther.</i> 2013; <b>137</b>(2): 200â15. <a target=xrefwindow id=d36060e1625 href="http://www.ncbi.nlm.nih.gov/pubmed/23064233">PubMed Abstract </a> | <a target=xrefwindow id=d36060e1628 href="http://dx.doi.org/10.1016/j.pharmthera.2012.10.003">Publisher Full Text </a> | <a target=xrefwindow id=d36060e1631 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3556178">Free Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d36060e1640 class=n-a></a>Marcucci F, Bellone M, Caserta CA, <i> et al.</i>: Pushing tumor cells towards a malignant phenotype: stimuli from the microenvironment, intercellular communications and alternative roads. <i>Int J Cancer.</i> 2014; <b>135</b>(6): 1265â76. <a target=xrefwindow id=d36060e1651 href="http://www.ncbi.nlm.nih.gov/pubmed/24174383">PubMed Abstract </a> | <a target=xrefwindow id=d36060e1654 href="http://dx.doi.org/10.1002/ijc.28572">Publisher Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727286386"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d36060e1663 class=n-a></a>Lambert AW, Pattabiraman DR, Weinberg RA: Emerging Biological Principles of Metastasis. <i>Cell.</i> 2017; <b>168</b>(4): 670â91. <a target=xrefwindow id=d36060e1671 href="http://www.ncbi.nlm.nih.gov/pubmed/28187288">PubMed Abstract </a> | <a target=xrefwindow id=d36060e1674 href="http://dx.doi.org/10.1016/j.cell.2016.11.037">Publisher Full Text </a> | <a target=xrefwindow id=d36060e1677 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5308465">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727286386">F1000 Recommendation</a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d36060e1691 class=n-a></a>Ganguly KK, Pal S, Moulik S, <i> et al.</i>: Integrins and metastasis. <i>Cell Adh Migr.</i> 2013; <b>7</b>(3): 251â61. <a target=xrefwindow id=d36060e1702 href="http://www.ncbi.nlm.nih.gov/pubmed/23563505">PubMed Abstract </a> | <a target=xrefwindow id=d36060e1705 href="http://dx.doi.org/10.4161/cam.23840">Publisher Full Text </a> | <a target=xrefwindow id=d36060e1709 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3711990">Free Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d36060e1718 class=n-a></a>Seguin L, Desgrosellier JS, Weis SM, <i> et al.</i>: Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance. <i>Trends Cell Biol.</i> 2015; <b>25</b>(4): 234â40. <a target=xrefwindow id=d36060e1729 href="http://www.ncbi.nlm.nih.gov/pubmed/25572304">PubMed Abstract </a> | <a target=xrefwindow id=d36060e1732 href="http://dx.doi.org/10.1016/j.tcb.2014.12.006">Publisher Full Text </a> | <a target=xrefwindow id=d36060e1736 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4380531">Free Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d36060e1745 class=n-a></a>Guo W, Giancotti FG: Integrin signalling during tumour progression. <i>Nat Rev Mol Cell Biol.</i> 2004; <b>5</b>(10): 816â26. <a target=xrefwindow id=d36060e1753 href="http://www.ncbi.nlm.nih.gov/pubmed/15459662">PubMed Abstract </a> | <a target=xrefwindow id=d36060e1756 href="http://dx.doi.org/10.1038/nrm1490">Publisher Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d36060e1765 class=n-a></a>Guan X: Cancer metastases: challenges and opportunities. <i>Acta Pharm Sin B.</i> 2015; <b>5</b>(5): 402â18. <a target=xrefwindow id=d36060e1773 href="http://www.ncbi.nlm.nih.gov/pubmed/26579471">PubMed Abstract </a> | <a target=xrefwindow id=d36060e1776 href="http://dx.doi.org/10.1016/j.apsb.2015.07.005">Publisher Full Text </a> | <a target=xrefwindow id=d36060e1779 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4629446">Free Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d36060e1788 class=n-a></a>Santosh AB, Jones T, Harvey J: A review on oral cancer biomarkers: Understanding the past and learning from the present. <i>J Cancer Res Ther.</i> 2016; <b>12</b>(2): 486â92. <a target=xrefwindow id=d36060e1796 href="http://www.ncbi.nlm.nih.gov/pubmed/27461598">PubMed Abstract </a> | <a target=xrefwindow id=d36060e1799 href="http://dx.doi.org/10.4103/0973-1482.176414">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d36060e1808 class=n-a></a>NisticÃ² P, Di Modugno F, Spada S, <i> et al.</i>: Î²1 and Î²4 integrins: from breast development to clinical practice. <i>Breast Cancer Res.</i> 2014; <b>16</b>(5): 459. <a target=xrefwindow id=d36060e1819 href="http://www.ncbi.nlm.nih.gov/pubmed/25606594">PubMed Abstract </a> | <a target=xrefwindow id=d36060e1822 href="http://dx.doi.org/10.1186/s13058-014-0459-x">Publisher Full Text </a> | <a target=xrefwindow id=d36060e1826 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4384274">Free Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725797114"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d36060e1836 class=n-a></a>Carpenter BL, Chen M, Knifley T, <i> et al.</i>: Integrin Î±6Î²4 Promotes Autocrine Epidermal Growth Factor Receptor (EGFR) Signaling to Stimulate Migration and Invasion toward Hepatocyte Growth Factor (HGF). <i>J Biol Chem.</i> 2015; <b>290</b>(45): 27228â38. <a target=xrefwindow id=d36060e1847 href="http://www.ncbi.nlm.nih.gov/pubmed/26381405">PubMed Abstract </a> | <a target=xrefwindow id=d36060e1850 href="http://dx.doi.org/10.1074/jbc.M115.686873">Publisher Full Text </a> | <a target=xrefwindow id=d36060e1854 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4646402">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725797114">F1000 Recommendation</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d36060e1867 class=n-a></a>Larsen M, Artym VV, Green JA, <i> et al.</i>: The matrix reorganized: extracellular matrix remodeling and integrin signaling. <i>Curr Opin Cell Biol.</i> 2006; <b>18</b>(5): 463â71. <a target=xrefwindow id=d36060e1878 href="http://www.ncbi.nlm.nih.gov/pubmed/16919434">PubMed Abstract </a> | <a target=xrefwindow id=d36060e1881 href="http://dx.doi.org/10.1016/j.ceb.2006.08.009">Publisher Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d36060e1890 class=n-a></a>Yue J, Zhang K, Chen J: Role of integrins in regulating proteases to mediate extracellular matrix remodeling. <i>Cancer Microenviron.</i> 2012; <b>5</b>(3): 275â83. <a target=xrefwindow id=d36060e1898 href="http://www.ncbi.nlm.nih.gov/pubmed/22437309">PubMed Abstract </a> | <a target=xrefwindow id=d36060e1901 href="http://dx.doi.org/10.1007/s12307-012-0101-3">Publisher Full Text </a> | <a target=xrefwindow id=d36060e1904 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3460049">Free Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d36060e1913 class=n-a></a>Lu P, Weaver VM, Werb Z: The extracellular matrix: a dynamic niche in cancer progression. <i>J Cell Biol.</i> 2012; <b>196</b>(4): 395â406. <a target=xrefwindow id=d36060e1921 href="http://www.ncbi.nlm.nih.gov/pubmed/22351925">PubMed Abstract </a> | <a target=xrefwindow id=d36060e1924 href="http://dx.doi.org/10.1083/jcb.201102147">Publisher Full Text </a> | <a target=xrefwindow id=d36060e1927 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3283993">Free Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d36060e1936 class=n-a></a>McCawley LJ, Matrisian LM: Matrix metalloproteinases: theyâre not just for matrix anymore! <i>Curr Opin Cell Biol.</i> 2001; <b>13</b>(5): 534â40. <a target=xrefwindow id=d36060e1944 href="http://www.ncbi.nlm.nih.gov/pubmed/11544020">PubMed Abstract </a> | <a target=xrefwindow id=d36060e1947 href="http://dx.doi.org/10.1016/S0955-0674(00)00248-9">Publisher Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d36060e1956 class=n-a></a>Coussens LM, Tinkle CL, Hanahan D, <i> et al.</i>: MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. <i>Cell.</i> 2000; <b>103</b>(3): 481â90. <a target=xrefwindow id=d36060e1967 href="http://www.ncbi.nlm.nih.gov/pubmed/11081634">PubMed Abstract </a> | <a target=xrefwindow id=d36060e1970 href="http://dx.doi.org/10.1016/S0092-8674(00)00139-2">Publisher Full Text </a> | <a target=xrefwindow id=d36060e1974 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2843102">Free Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d36060e1984 class=n-a></a>Yu Q, Stamenkovic I: Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. <i>Genes Dev.</i> 2000; <b>14</b>(2): 163â76. <a target=xrefwindow id=d36060e1992 href="http://www.ncbi.nlm.nih.gov/pubmed/10652271">PubMed Abstract </a> | <a target=xrefwindow id=d36060e1995 href="http://www.ncbi.nlm.nih.gov/pmc/articles/316345">Free Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d36060e2004 class=n-a></a>Khan Z, Marshall JF: The role of integrins in TGFÎ² activation in the tumour stroma. <i>Cell Tissue Res.</i> 2016; <b>365</b>(3): 657â73. <a target=xrefwindow id=d36060e2012 href="http://www.ncbi.nlm.nih.gov/pubmed/27515461">PubMed Abstract </a> | <a target=xrefwindow id=d36060e2015 href="http://dx.doi.org/10.1007/s00441-016-2474-y">Publisher Full Text </a> | <a target=xrefwindow id=d36060e2018 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5010607">Free Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d36060e2027 class=n-a></a>Vasudev NS, Reynolds AR: Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions. <i>Angiogenesis.</i> 2014; <b>17</b>(3): 471â94. <a target=xrefwindow id=d36060e2035 href="http://www.ncbi.nlm.nih.gov/pubmed/24482243">PubMed Abstract </a> | <a target=xrefwindow id=d36060e2038 href="http://dx.doi.org/10.1007/s10456-014-9420-y">Publisher Full Text </a> | <a target=xrefwindow id=d36060e2041 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4061466">Free Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d36060e2050 class=n-a></a>Liu S, Liu J, Ma Q, <i> et al.</i>: Solid tumor therapy by selectively targeting stromal endothelial cells. <i>Proc Natl Acad Sci U S A.</i> 2016; <b>113</b>(28): E4079â87. <a target=xrefwindow id=d36060e2061 href="http://www.ncbi.nlm.nih.gov/pubmed/27357689">PubMed Abstract </a> | <a target=xrefwindow id=d36060e2064 href="http://dx.doi.org/10.1073/pnas.1600982113">Publisher Full Text </a> | <a target=xrefwindow id=d36060e2068 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4948345">Free Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d36060e2077 class=n-a></a>Hynes RO: A reevaluation of integrins as regulators of angiogenesis. <i>Nat Med.</i> 2002; <b>8</b>(9): 918â21. <a target=xrefwindow id=d36060e2085 href="http://www.ncbi.nlm.nih.gov/pubmed/12205444">PubMed Abstract </a> | <a target=xrefwindow id=d36060e2088 href="http://dx.doi.org/10.1038/nm0902-918">Publisher Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d36060e2097 class=n-a></a>Demircioglu F, Hodivala-Dilke K: Î±vÎ²3 Integrin and tumour blood vessels-learning from the past to shape the future. <i>Curr Opin Cell Biol.</i> 2016; <b>42</b>: 121â7. <a target=xrefwindow id=d36060e2105 href="http://www.ncbi.nlm.nih.gov/pubmed/27474973">PubMed Abstract </a> | <a target=xrefwindow id=d36060e2108 href="http://dx.doi.org/10.1016/j.ceb.2016.07.008">Publisher Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d36060e2118 class=n-a></a>Weis SM, Cheresh DA: Î±V integrins in angiogenesis and cancer. <i>Cold Spring Harb Perspect Med.</i> 2011; <b>1</b>(1): a006478. <a target=xrefwindow id=d36060e2126 href="http://www.ncbi.nlm.nih.gov/pubmed/22229119">PubMed Abstract </a> | <a target=xrefwindow id=d36060e2129 href="http://dx.doi.org/10.1101/cshperspect.a006478">Publisher Full Text </a> | <a target=xrefwindow id=d36060e2132 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3234453">Free Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d36060e2141 class=n-a></a>Laurens N, Engelse MA, Jungerius C, <i> et al.</i>: Single and combined effects of alphavbeta3- and alpha5beta1-integrins on capillary tube formation in a human fibrinous matrix. <i>Angiogenesis.</i> 2009; <b>12</b>(3): 275â85. <a target=xrefwindow id=d36060e2152 href="http://www.ncbi.nlm.nih.gov/pubmed/19449108">PubMed Abstract </a> | <a target=xrefwindow id=d36060e2155 href="http://dx.doi.org/10.1007/s10456-009-9150-8">Publisher Full Text </a> | <a target=xrefwindow id=d36060e2159 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2752504">Free Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725403599"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d36060e2168 class=n-a></a>Murphy PA, Begum S, Hynes RO: Tumor angiogenesis in the absence of fibronectin or its cognate integrin receptors. <i>PLoS One.</i> 2015; <b>10</b>(3): e0120872. <a target=xrefwindow id=d36060e2176 href="http://www.ncbi.nlm.nih.gov/pubmed/25807551">PubMed Abstract </a> | <a target=xrefwindow id=d36060e2179 href="http://dx.doi.org/10.1371/journal.pone.0120872">Publisher Full Text </a> | <a target=xrefwindow id=d36060e2182 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4373772">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725403599">F1000 Recommendation</a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d36060e2195 class=n-a></a>Ghatak S, Niland S, Schulz JN, <i> et al.</i>: Role of Integrins Î±1Î²1 and Î±2Î²1 in Wound and Tumor Angiogenesis in Mice. <i>Am J Pathol.</i> 2016; <b>186</b>(11): 3011â27. <a target=xrefwindow id=d36060e2206 href="http://www.ncbi.nlm.nih.gov/pubmed/27639165">PubMed Abstract </a> | <a target=xrefwindow id=d36060e2209 href="http://dx.doi.org/10.1016/j.ajpath.2016.06.021">Publisher Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1026014"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d36060e2218 class=n-a></a>Garmy-Susini B, Jin H, Zhu Y, <i> et al.</i>: Integrin alpha4beta1-VCAM-1-mediated adhesion between endothelial and mural cells is required for blood vessel maturation. <i>J Clin Invest.</i> 2005; <b>115</b>(6): 1542â51. <a target=xrefwindow id=d36060e2229 href="http://www.ncbi.nlm.nih.gov/pubmed/15902308">PubMed Abstract </a> | <a target=xrefwindow id=d36060e2232 href="http://dx.doi.org/10.1172/JCI23445">Publisher Full Text </a> | <a target=xrefwindow id=d36060e2236 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1088016">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1026014">F1000 Recommendation</a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d36060e2249 class=n-a></a>Jin H, Su J, Garmy-Susini B, <i> et al.</i>: Integrin alpha4beta1 promotes monocyte trafficking and angiogenesis in tumors. <i>Cancer Res.</i> 2006; <b>66</b>(4): 2146â52. <a target=xrefwindow id=d36060e2260 href="http://www.ncbi.nlm.nih.gov/pubmed/16489015">PubMed Abstract </a> | <a target=xrefwindow id=d36060e2263 href="http://dx.doi.org/10.1158/0008-5472.CAN-05-2704">Publisher Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d36060e2273 class=n-a></a>Avraamides CJ, Garmy-Susini B, Varner JA: Integrins in angiogenesis and lymphangiogenesis. <i>Nat Rev Cancer.</i> 2008; <b>8</b>(8): 604â17. <a target=xrefwindow id=d36060e2281 href="http://www.ncbi.nlm.nih.gov/pubmed/18497750">PubMed Abstract </a> | <a target=xrefwindow id=d36060e2284 href="http://dx.doi.org/10.1038/nrc2353">Publisher Full Text </a> | <a target=xrefwindow id=d36060e2287 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2577722">Free Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d36060e2296 class=n-a></a>Desai D, Singh P, Van De Water L, <i> et al.</i>: Dynamic Regulation of Integrin Î±<sub>6</sub>Î²<sub>4</sub> During Angiogenesis: Potential Implications for Pathogenic Wound Healing. <i>Adv Wound Care (New Rochelle).</i> 2013; <b>2</b>(8): 401â9. <a target=xrefwindow id=d36060e2314 href="http://www.ncbi.nlm.nih.gov/pubmed/24527356">PubMed Abstract </a> | <a target=xrefwindow id=d36060e2317 href="http://dx.doi.org/10.1089/wound.2013.0455">Publisher Full Text </a> | <a target=xrefwindow id=d36060e2320 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3797448">Free Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d36060e2329 class=n-a></a>Nikolopoulos SN, Blaikie P, Yoshioka T, <i> et al.</i>: Integrin beta4 signaling promotes tumor angiogenesis. <i>Cancer Cell.</i> 2004; <b>6</b>(5): 471â83. <a target=xrefwindow id=d36060e2340 href="http://www.ncbi.nlm.nih.gov/pubmed/15542431">PubMed Abstract </a> | <a target=xrefwindow id=d36060e2343 href="http://dx.doi.org/10.1016/j.ccr.2004.09.029">Publisher Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d36060e2352 class=n-a></a>Germain M, De Arcangelis A, Robinson SD, <i> et al.</i>: Genetic ablation of the alpha 6-integrin subunit in Tie1Cre mice enhances tumour angiogenesis. <i>J Pathol.</i> 2010; <b>220</b>(3): 370â81. <a target=xrefwindow id=d36060e2363 href="http://www.ncbi.nlm.nih.gov/pubmed/19967723">PubMed Abstract </a> | <a target=xrefwindow id=d36060e2366 href="http://dx.doi.org/10.1002/path.2654">Publisher Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d36060e2375 class=n-a></a>da Silva RG, Tavora B, Robinson SD, <i> et al.</i>: Endothelial alpha3beta1-integrin represses pathological angiogenesis and sustains endothelial-VEGF. <i>Am J Pathol.</i> 2010; <b>177</b>(3): 1534â48. <a target=xrefwindow id=d36060e2386 href="http://www.ncbi.nlm.nih.gov/pubmed/20639457">PubMed Abstract </a> | <a target=xrefwindow id=d36060e2389 href="http://dx.doi.org/10.2353/ajpath.2010.100043">Publisher Full Text </a> | <a target=xrefwindow id=d36060e2393 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2928983">Free Full Text </a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d36060e2402 class=n-a></a>Morini M, Mottolese M, Ferrari N, <i> et al.</i>: The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity. <i>Int J Cancer.</i> 2000; <b>87</b>(3): 336â42. <a target=xrefwindow id=d36060e2413 href="http://www.ncbi.nlm.nih.gov/pubmed/10897037">PubMed Abstract </a> | <a target="xrefwindow" id="d36060e2416" href="http://dx.doi.org/10.1002/1097-0215(20000801)87:3<336::AID-IJC5&gt;3.0.CO;2-3">Publisher Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d36060e2426 class=n-a></a>Mitchell K, Svenson KB, Longmate WM, <i> et al.</i>: Suppression of integrin alpha3beta1 in breast cancer cells reduces <i>cyclooxygenase-2</i> gene expression and inhibits tumorigenesis, invasion, and cross-talk to endothelial cells. <i>Cancer Res.</i> 2010; <b>70</b>(15): 6359â67. <a target=xrefwindow id=d36060e2440 href="http://www.ncbi.nlm.nih.gov/pubmed/20631072">PubMed Abstract </a> | <a target=xrefwindow id=d36060e2444 href="http://dx.doi.org/10.1158/0008-5472.CAN-09-4283">Publisher Full Text </a> | <a target=xrefwindow id=d36060e2447 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2913124">Free Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d36060e2456 class=n-a></a>Mitchell K, Szekeres C, Milano V, <i> et al.</i>: Alpha3beta1 integrin in epidermis promotes wound angiogenesis and keratinocyte-to-endothelial-cell crosstalk through the induction of MRP3. <i>J Cell Sci.</i> 2009; <b>122</b>(Pt 11): 1778â87. <a target=xrefwindow id=d36060e2467 href="http://www.ncbi.nlm.nih.gov/pubmed/19435806">PubMed Abstract </a> | <a target=xrefwindow id=d36060e2470 href="http://dx.doi.org/10.1242/jcs.040956">Publisher Full Text </a> | <a target=xrefwindow id=d36060e2474 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2684832">Free Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d36060e2483 class=n-a></a>Chung J, Bachelder RE, Lipscomb EA, <i> et al.</i>: Integrin (alpha 6 beta 4) regulation of eIF-4E activity and VEGF translation: a survival mechanism for carcinoma cells. <i>J Cell Biol.</i> 2002; <b>158</b>(1): 165â74. <a target=xrefwindow id=d36060e2494 href="http://www.ncbi.nlm.nih.gov/pubmed/12105188">PubMed Abstract </a> | <a target=xrefwindow id=d36060e2497 href="http://dx.doi.org/10.1083/jcb.200112015">Publisher Full Text </a> | <a target=xrefwindow id=d36060e2501 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2173018">Free Full Text </a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727521403"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d36060e2510 class=n-a></a>Longmate WM, Lyons SP, Chittur SV, <i> et al.</i>: Suppression of integrin Î±3Î²1 by Î±9Î²1 in the epidermis controls the paracrine resolution of wound angiogenesis. <i>J Cell Biol.</i> 2017; <b>216</b>(5): 1473â88. <a target=xrefwindow id=d36060e2521 href="http://www.ncbi.nlm.nih.gov/pubmed/28416479">PubMed Abstract </a> | <a target=xrefwindow id=d36060e2524 href="http://dx.doi.org/10.1083/jcb.201510042">Publisher Full Text </a> | <a target=xrefwindow id=d36060e2528 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5412555">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727521403">F1000 Recommendation</a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1020091"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d36060e2541 class=n-a></a>Calderwood DA, Tai V, Di Paolo G, <i> et al.</i>: Competition for talin results in trans-dominant inhibition of integrin activation. <i>J Biol Chem.</i> 2004; <b>279</b>(28): 28889â95. <a target=xrefwindow id=d36060e2552 href="http://www.ncbi.nlm.nih.gov/pubmed/15143061">PubMed Abstract </a> | <a target=xrefwindow id=d36060e2555 href="http://dx.doi.org/10.1074/jbc.M402161200">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1020091">F1000 Recommendation</a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d36060e2568 class=n-a></a>DÃ­az-GonzÃ¡lez F, Forsyth J, Steiner B, <i> et al.</i>: Trans-dominant inhibition of integrin function. <i>Mol Biol Cell.</i> 1996; <b>7</b>(12): 1939â51. <a target=xrefwindow id=d36060e2579 href="http://www.ncbi.nlm.nih.gov/pubmed/8970156">PubMed Abstract </a> | <a target=xrefwindow id=d36060e2582 href="http://dx.doi.org/10.1091/mbc.7.12.1939">Publisher Full Text </a> | <a target=xrefwindow id=d36060e2586 href="http://www.ncbi.nlm.nih.gov/pmc/articles/276041">Free Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d36060e2596 class=n-a></a>Hodivala-Dilke KM, DiPersio CM, Kreidberg JA, <i> et al.</i>: Novel roles for alpha3beta1 integrin as a regulator of cytoskeletal assembly and as a trans-dominant inhibitor of integrin receptor function in mouse keratinocytes. <i>J Cell Biol.</i> 1998; <b>142</b>(5): 1357â69. <a target=xrefwindow id=d36060e2607 href="http://www.ncbi.nlm.nih.gov/pubmed/9732295">PubMed Abstract </a> | <a target=xrefwindow id=d36060e2610 href="http://dx.doi.org/10.1083/jcb.142.5.1357">Publisher Full Text </a> | <a target=xrefwindow id=d36060e2614 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2149349">Free Full Text </a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/9499956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d36060e2623 class=n-a></a>Hanahan D, Weinberg RA: Hallmarks of cancer: the next generation. <i>Cell.</i> 2011; <b>144</b>(5): 646â74. <a target=xrefwindow id=d36060e2631 href="http://www.ncbi.nlm.nih.gov/pubmed/21376230">PubMed Abstract </a> | <a target=xrefwindow id=d36060e2634 href="http://dx.doi.org/10.1016/j.cell.2011.02.013">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/9499956">F1000 Recommendation</a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d36060e2647 class=n-a></a>Joyce JA, Pollard JW: Microenvironmental regulation of metastasis. <i>Nat Rev Cancer.</i> 2009; <b>9</b>(4): 239â52. <a target=xrefwindow id=d36060e2655 href="http://www.ncbi.nlm.nih.gov/pubmed/19279573">PubMed Abstract </a> | <a target=xrefwindow id=d36060e2658 href="http://dx.doi.org/10.1038/nrc2618">Publisher Full Text </a> | <a target=xrefwindow id=d36060e2661 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3251309">Free Full Text </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a name=d36060e2670 class=n-a></a>Kharaishvili G, Simkova D, Bouchalova K, <i> et al.</i>: The role of cancer-associated fibroblasts, solid stress and other microenvironmental factors in tumor progression and therapy resistance. <i>Cancer Cell Int.</i> 2014; <b>14</b>: 41. <a target=xrefwindow id=d36060e2681 href="http://www.ncbi.nlm.nih.gov/pubmed/24883045">PubMed Abstract </a> | <a target=xrefwindow id=d36060e2684 href="http://dx.doi.org/10.1186/1475-2867-14-41">Publisher Full Text </a> | <a target=xrefwindow id=d36060e2688 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4038849">Free Full Text </a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d36060e2697 class=n-a></a>Alexander J, Cukierman E: Stromal dynamic reciprocity in cancer: intricacies of fibroblastic-ECM interactions. <i>Curr Opin Cell Biol.</i> 2016; <b>42</b>: 80â93. <a target=xrefwindow id=d36060e2705 href="http://www.ncbi.nlm.nih.gov/pubmed/27214794">PubMed Abstract </a> | <a target=xrefwindow id=d36060e2708 href="http://dx.doi.org/10.1016/j.ceb.2016.05.002">Publisher Full Text </a> | <a target=xrefwindow id=d36060e2711 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5064819">Free Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a name=d36060e2720 class=n-a></a>Hinz B: The myofibroblast: paradigm for a mechanically active cell. <i>J Biomech.</i> 2010; <b>43</b>(1): 146â55. <a target=xrefwindow id=d36060e2728 href="http://www.ncbi.nlm.nih.gov/pubmed/19800625">PubMed Abstract </a> | <a target=xrefwindow id=d36060e2731 href="http://dx.doi.org/10.1016/j.jbiomech.2009.09.020">Publisher Full Text </a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726354594"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d36060e2741 class=n-a></a>Gao AE, Sullivan KE, Black LD 3rd: Lysyl oxidase expression in cardiac fibroblasts is regulated by Î±2Î²1 integrin interactions with the cellular microenvironment. <i>Biochem Biophys Res Commun.</i> 2016; <b>475</b>(1): 70â5. <a target=xrefwindow id=d36060e2749 href="http://www.ncbi.nlm.nih.gov/pubmed/27169768">PubMed Abstract </a> | <a target=xrefwindow id=d36060e2752 href="http://dx.doi.org/10.1016/j.bbrc.2016.05.037">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726354594">F1000 Recommendation</a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726934235"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d36060e2765 class=n-a></a>Sun Z, Guo SS, FÃ¤ssler R: Integrin-mediated mechanotransduction. <i>J Cell Biol.</i> 2016; <b>215</b>(4): 445â56. <a target=xrefwindow id=d36060e2773 href="http://www.ncbi.nlm.nih.gov/pubmed/27872252">PubMed Abstract </a> | <a target=xrefwindow id=d36060e2776 href="http://dx.doi.org/10.1083/jcb.201609037">Publisher Full Text </a> | <a target=xrefwindow id=d36060e2779 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5119943">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726934235">F1000 Recommendation</a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1281979"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d36060e2792 class=n-a></a>Levental KR, Yu H, Kass L, <i> et al.</i>: Matrix crosslinking forces tumor progression by enhancing integrin signaling. <i>Cell.</i> 2009; <b>139</b>(5): 891â906. <a target=xrefwindow id=d36060e2803 href="http://www.ncbi.nlm.nih.gov/pubmed/19931152">PubMed Abstract </a> | <a target=xrefwindow id=d36060e2806 href="http://dx.doi.org/10.1016/j.cell.2009.10.027">Publisher Full Text </a> | <a target=xrefwindow id=d36060e2810 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2788004">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1281979">F1000 Recommendation</a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d36060e2823 class=n-a></a>Bissell MJ, Hall HG, Parry G: How does the extracellular matrix direct gene expression? <i>J Theor Biol.</i> 1982; <b>99</b>(1): 31â68. <a target=xrefwindow id=d36060e2831 href="http://www.ncbi.nlm.nih.gov/pubmed/6892044">PubMed Abstract </a> | <a target=xrefwindow id=d36060e2834 href="http://dx.doi.org/10.1016/0022-5193(82)90388-5">Publisher Full Text </a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a name=d36060e2843 class=n-a></a>Handorf AM, Zhou Y, Halanski MA, <i> et al.</i>: Tissue stiffness dictates development, homeostasis, and disease progression. <i>Organogenesis.</i> 2015; <b>11</b>(1): 1â15. <a target=xrefwindow id=d36060e2854 href="http://www.ncbi.nlm.nih.gov/pubmed/25915734">PubMed Abstract </a> | <a target=xrefwindow id=d36060e2857 href="http://dx.doi.org/10.1080/15476278.2015.1019687">Publisher Full Text </a> | <a target=xrefwindow id=d36060e2861 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4594591">Free Full Text </a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725813904"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d36060e2870 class=n-a></a>Izumi D, Ishimoto T, Miyake K, <i> et al.</i>: CXCL12/CXCR4 activation by cancer-associated fibroblasts promotes integrin Î²1 clustering and invasiveness in gastric cancer. <i>Int J Cancer.</i> 2016; <b>138</b>(5): 1207â19. <a target=xrefwindow id=d36060e2881 href="http://www.ncbi.nlm.nih.gov/pubmed/26414794">PubMed Abstract </a> | <a target=xrefwindow id=d36060e2884 href="http://dx.doi.org/10.1002/ijc.29864">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725813904">F1000 Recommendation</a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725507695"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d36060e2898 class=n-a></a>Yuan J, Liu M, Yang L, <i> et al.</i>: Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and Î²1-integrin signaling pathway in tumor cells. <i>Breast Cancer Res.</i> 2015; <b>17</b>(1): 69. <a target=xrefwindow id=d36060e2909 href="http://www.ncbi.nlm.nih.gov/pubmed/25990368">PubMed Abstract </a> | <a target=xrefwindow id=d36060e2912 href="http://dx.doi.org/10.1186/s13058-015-0579-y">Publisher Full Text </a> | <a target=xrefwindow id=d36060e2916 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4453053">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725507695">F1000 Recommendation</a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/729079439"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d36060e2929 class=n-a></a>Grudowska A, CzapliÅska D, Polom W, <i> et al.</i>: Tetraspanin CD151 mediates communication between PC3 prostate cancer cells and osteoblasts. <i>Acta Biochim Pol.</i> 2017; <b>64</b>(1): 135â41. <a target=xrefwindow id=d36060e2940 href="http://www.ncbi.nlm.nih.gov/pubmed/28291843">PubMed Abstract </a> | <a target=xrefwindow id=d36060e2943 href="http://dx.doi.org/10.18388/abp.2016_1356">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/729079439">F1000 Recommendation</a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a name=d36060e2956 class=n-a></a>He Y, Liu XD, Chen ZY, <i> et al.</i>: Interaction between cancer cells and stromal fibroblasts is required for activation of the uPAR-uPA-MMP-2 cascade in pancreatic cancer metastasis. <i>Clin Cancer Res.</i> 2007; <b>13</b>(11): 3115â24. <a target=xrefwindow id=d36060e2967 href="http://www.ncbi.nlm.nih.gov/pubmed/17545513">PubMed Abstract </a> | <a target=xrefwindow id=d36060e2970 href="http://dx.doi.org/10.1158/1078-0432.CCR-06-2088">Publisher Full Text </a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a name=d36060e2979 class=n-a></a>Zheng X, Turkowski K, Mora J, <i> et al.</i>: Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy. <i>Oncotarget.</i> 2017; <b>8</b>(29): 48436â48452. <a target=xrefwindow id=d36060e2990 href="http://www.ncbi.nlm.nih.gov/pubmed/28467800">PubMed Abstract </a> | <a target=xrefwindow id=d36060e2993 href="http://dx.doi.org/10.18632/oncotarget.17061">Publisher Full Text </a> | <a target=xrefwindow id=d36060e2997 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5564660">Free Full Text </a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a name=d36060e3006 class=n-a></a>Goswami KK, Ghosh T, Ghosh S, <i> et al.</i>: Tumor promoting role of anti-tumor macrophages in tumor microenvironment. <i>Cell Immunol.</i> 2017; <b>316</b>: 1â10. <a target=xrefwindow id=d36060e3017 href="http://www.ncbi.nlm.nih.gov/pubmed/28433198">PubMed Abstract </a> | <a target=xrefwindow id=d36060e3020 href="http://dx.doi.org/10.1016/j.cellimm.2017.04.005">Publisher Full Text </a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a name=d36060e3029 class=n-a></a>Guo Q, Jin Z, Yuan Y, <i> et al.</i>: New Mechanisms of Tumor-Associated Macrophages on Promoting Tumor Progression: Recent Research Advances and Potential Targets for Tumor Immunotherapy. <i>J Immunol Res.</i> 2016; <b>2016</b>: 9720912. <a target=xrefwindow id=d36060e3040 href="http://www.ncbi.nlm.nih.gov/pubmed/27975071">PubMed Abstract </a> | <a target=xrefwindow id=d36060e3043 href="http://dx.doi.org/10.1155/2016/9720912">Publisher Full Text </a> | <a target=xrefwindow id=d36060e3047 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5128713">Free Full Text </a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a name=d36060e3057 class=n-a></a>Kale S, Raja R, Thorat D, <i> et al.</i>: Osteopontin signaling upregulates cyclooxygenase-2 expression in tumor-associated macrophages leading to enhanced angiogenesis and melanoma growth via Î±9Î²1 integrin. <i>Oncogene.</i> 2014; <b>33</b>(18): 2295â306. <a target=xrefwindow id=d36060e3068 href="http://www.ncbi.nlm.nih.gov/pubmed/23728342">PubMed Abstract </a> | <a target=xrefwindow id=d36060e3071 href="http://dx.doi.org/10.1038/onc.2013.184">Publisher Full Text </a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725308729"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d36060e3080 class=n-a></a>Zhou W, Ke SQ, Huang Z, <i> et al.</i>: Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth. <i>Nat Cell Biol.</i> 2015; <b>17</b>(2): 170â82. <a target=xrefwindow id=d36060e3091 href="http://www.ncbi.nlm.nih.gov/pubmed/25580734">PubMed Abstract </a> | <a target=xrefwindow id=d36060e3094 href="http://dx.doi.org/10.1038/ncb3090">Publisher Full Text </a> | <a target=xrefwindow id=d36060e3098 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4312504">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725308729">F1000 Recommendation</a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a name=d36060e3111 class=n-a></a>Bai J, Adriani G, Dang T, <i> et al.</i>: Contact-dependent carcinoma aggregate dispersion by M2a macrophages via ICAM-1 and Î²2 integrin interactions. <i>Oncotarget.</i> 2015; <b>6</b>(28): 25295â307. <a target=xrefwindow id=d36060e3122 href="http://www.ncbi.nlm.nih.gov/pubmed/26231039">PubMed Abstract </a> | <a target=xrefwindow id=d36060e3125 href="http://dx.doi.org/10.18632/oncotarget.4716">Publisher Full Text </a> | <a target=xrefwindow id=d36060e3129 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4694832">Free Full Text </a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a name=d36060e3138 class=n-a></a>Yamada S, Bu X, Khankaldyyan V, <i> et al.</i>: Effect of the angiogenesis inhibitor Cilengitide (EMD 121974) on glioblastoma growth in nude mice. <i>Neurosurgery.</i> 2006; <b>59</b>(6): 1304â12; discussion 1312. <a target=xrefwindow id=d36060e3149 href="http://www.ncbi.nlm.nih.gov/pubmed/17277694">PubMed Abstract </a> | <a target=xrefwindow id=d36060e3152 href="http://dx.doi.org/10.1227/01.NEU.0000245622.70344.BE">Publisher Full Text </a></span></li><li><a name=ref-94 class=n-a></a><span class=label>94. </span>&nbsp;<span class=citation><a name=d36060e3161 class=n-a></a>Ley K, Rivera-Nieves J, Sandborn WJ, <i> et al.</i>: Integrin-based therapeutics: biological basis, clinical use and new drugs. <i>Nat Rev Drug Discov.</i> 2016; <b>15</b>(3): 173â83. <a target=xrefwindow id=d36060e3172 href="http://www.ncbi.nlm.nih.gov/pubmed/26822833">PubMed Abstract </a> | <a target=xrefwindow id=d36060e3175 href="http://dx.doi.org/10.1038/nrd.2015.10">Publisher Full Text </a> | <a target=xrefwindow id=d36060e3179 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4890615">Free Full Text </a></span></li><li><a name=ref-95 class=n-a></a><span class=label>95. </span>&nbsp;<span class=citation><a name=d36060e3188 class=n-a></a>Singh H, Grewal N, Arora E, <i> et al.</i>: Vedolizumab: A novel anti-integrin drug for treatment of inflammatory bowel disease. <i>J Nat Sci Biol Med.</i> 2016; <b>7</b>(1): 4â9. <a target=xrefwindow id=d36060e3199 href="http://www.ncbi.nlm.nih.gov/pubmed/27003961">PubMed Abstract </a> | <a target=xrefwindow id=d36060e3202 href="http://dx.doi.org/10.4103/0976-9668.175016">Publisher Full Text </a> | <a target=xrefwindow id=d36060e3206 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4780165">Free Full Text </a></span></li><li><a name=ref-96 class=n-a></a><span class=label>96. </span>&nbsp;<span class=citation><a name=d36060e3216 class=n-a></a>Weller M, Nabors LB, Gorlia T, <i> et al.</i>: Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcome. <i>Oncotarget.</i> 2016; <b>7</b>(12): 15018â32. <a target=xrefwindow id=d36060e3227 href="http://www.ncbi.nlm.nih.gov/pubmed/26918452">PubMed Abstract </a> | <a target=xrefwindow id=d36060e3230 href="http://dx.doi.org/10.18632/oncotarget.7588">Publisher Full Text </a> | <a target=xrefwindow id=d36060e3234 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4924768">Free Full Text </a></span></li><li><a name=ref-97 class=n-a></a><span class=label>97. </span>&nbsp;<span class=citation><a name=d36060e3243 class=n-a></a>Paolillo M, Serra M, Schinelli S: Integrins in glioblastoma: Still an attractive target? <i>Pharmacol Res.</i> 2016; <b>113</b>(Pt A): 55â61. <a target=xrefwindow id=d36060e3251 href="http://www.ncbi.nlm.nih.gov/pubmed/27498157">PubMed Abstract </a> | <a target=xrefwindow id=d36060e3254 href="http://dx.doi.org/10.1016/j.phrs.2016.08.004">Publisher Full Text </a></span></li><li><a name=ref-98 class=n-a></a><span class=label>98. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725621211"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d36060e3263 class=n-a></a>Stewart RL, O'Connor KL: Clinical significance of the integrin <i>Î±</i>6<i>Î²</i>4 in human malignancies. <i>Lab Invest.</i> 2015; <b>95</b>(9): 976â86. <a target=xrefwindow id=d36060e3277 href="http://www.ncbi.nlm.nih.gov/pubmed/26121317">PubMed Abstract </a> | <a target=xrefwindow id=d36060e3281 href="http://dx.doi.org/10.1038/labinvest.2015.82">Publisher Full Text </a> | <a target=xrefwindow id=d36060e3284 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4554527">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725621211">F1000 Recommendation</a></span></li><li><a name=ref-99 class=n-a></a><span class=label>99. </span>&nbsp;<span class=citation><a name=d36060e3297 class=n-a></a>Weaver VM, LeliÃ¨vre S, Lakins JN, <i> et al.</i>: beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. <i>Cancer Cell.</i> 2002; <b>2</b>(3): 205â16. <a target=xrefwindow id=d36060e3308 href="http://www.ncbi.nlm.nih.gov/pubmed/12242153">PubMed Abstract </a> | <a target=xrefwindow id=d36060e3311 href="http://dx.doi.org/10.1016/S1535-6108(02)00125-3">Publisher Full Text </a> | <a target=xrefwindow id=d36060e3315 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2788997">Free Full Text </a></span></li><li><a name=ref-100 class=n-a></a><span class=label>100. </span>&nbsp;<span class=citation><a name=d36060e3324 class=n-a></a>Goel HL, Gritsko T, Pursell B, <i> et al.</i>: Regulated splicing of the Î±6 integrin cytoplasmic domain determines the fate of breast cancer stem cells. <i>Cell Rep.</i> 2014; <b>7</b>(3): 747â61. <a target=xrefwindow id=d36060e3335 href="http://www.ncbi.nlm.nih.gov/pubmed/24767994">PubMed Abstract </a> | <a target=xrefwindow id=d36060e3338 href="http://dx.doi.org/10.1016/j.celrep.2014.03.059">Publisher Full Text </a> | <a target=xrefwindow id=d36060e3342 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4038359">Free Full Text </a></span></li><li><a name=ref-101 class=n-a></a><span class=label>101. </span>&nbsp;<span class=citation><a name=d36060e3351 class=n-a></a>Davis TL, Cress AE, Dalkin BL, <i> et al.</i>: Unique expression pattern of the alpha6beta4 integrin and laminin-5 in human prostate carcinoma. <i>Prostate.</i> 2001; <b>46</b>(3): 240â8. <a target=xrefwindow id=d36060e3362 href="http://www.ncbi.nlm.nih.gov/pubmed/11170153">PubMed Abstract </a> | <a target="xrefwindow" id="d36060e3365" href="http://dx.doi.org/10.1002/1097-0045(20010215)46:3<240::AID-PROS1029&gt;3.0.CO;2-0%0A">Publisher Full Text </a> | <a target=xrefwindow id=d36060e3369 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2824426">Free Full Text </a></span></li><li><a name=ref-102 class=n-a></a><span class=label>102. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1115403"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d36060e3379 class=n-a></a>Yang XH, Richardson AL, Torres-Arzayus MI, <i> et al.</i>: CD151 accelerates breast cancer by regulating alpha 6 integrin function, signaling, and molecular organization. <i>Cancer Res.</i> 2008; <b>68</b>(9): 3204â13. <a target=xrefwindow id=d36060e3390 href="http://www.ncbi.nlm.nih.gov/pubmed/18451146">PubMed Abstract </a> | <a target=xrefwindow id=d36060e3393 href="http://dx.doi.org/10.1158/0008-5472.CAN-07-2949">Publisher Full Text </a> | <a target=xrefwindow id=d36060e3397 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4764302">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1115403">F1000 Recommendation</a></span></li><li><a name=ref-103 class=n-a></a><span class=label>103. </span>&nbsp;<span class=citation><a name=d36060e3410 class=n-a></a>Mercurio AM, Bachelder RE, Chung J, <i> et al.</i>: Integrin laminin receptors and breast carcinoma progression. <i>J Mammary Gland Biol Neoplasia.</i> 2001; <b>6</b>(3): 299â309. <a target=xrefwindow id=d36060e3421 href="http://www.ncbi.nlm.nih.gov/pubmed/11547899">PubMed Abstract </a> | <a target=xrefwindow id=d36060e3424 href="http://dx.doi.org/10.1023/A:1011323608064">Publisher Full Text </a></span></li><li><a name=ref-104 class=n-a></a><span class=label>104. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725349059"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d36060e3433 class=n-a></a>Eke I, Zscheppang K, Dickreuter E, <i> et al.</i>: Simultaneous Î²1 integrin-EGFR targeting and radiosensitization of human head and neck cancer. <i>J Natl Cancer Inst.</i> 2015; <b>107</b>(2): pii: dju419. <a target=xrefwindow id=d36060e3444 href="http://www.ncbi.nlm.nih.gov/pubmed/25663685">PubMed Abstract </a> | <a target=xrefwindow id=d36060e3447 href="http://dx.doi.org/10.1093/jnci/dju419">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725349059">F1000 Recommendation</a></span></li><li><a name=ref-105 class=n-a></a><span class=label>105. </span>&nbsp;<span class=citation><a name=d36060e3460 class=n-a></a>Nam JM, Onodera Y, Bissell MJ, <i> et al.</i>: Breast cancer cells in three-dimensional culture display an enhanced radioresponse after coordinate targeting of integrin alpha5beta1 and fibronectin. <i>Cancer Res.</i> 2010; <b>70</b>(13): 5238â48. <a target=xrefwindow id=d36060e3471 href="http://www.ncbi.nlm.nih.gov/pubmed/20516121">PubMed Abstract </a> | <a target=xrefwindow id=d36060e3474 href="http://dx.doi.org/10.1158/0008-5472.CAN-09-2319">Publisher Full Text </a> | <a target=xrefwindow id=d36060e3478 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2933183">Free Full Text </a></span></li><li><a name=ref-106 class=n-a></a><span class=label>106. </span>&nbsp;<span class=citation><a name=d36060e3487 class=n-a></a>SÃ¸rensen BH, Rasmussen LJ, Broberg BS, <i> et al.</i>: Integrin Î²<sub>1</sub>, Osmosensing, and Chemoresistance in Mouse Ehrlich Carcinoma Cells. <i>Cell Physiol Biochem.</i> 2015; <b>36</b>(1): 111â32. <a target=xrefwindow id=d36060e3501 href="http://www.ncbi.nlm.nih.gov/pubmed/25925201">PubMed Abstract </a> | <a target=xrefwindow id=d36060e3505 href="http://dx.doi.org/10.1159/000374057">Publisher Full Text </a></span></li><li><a name=ref-107 class=n-a></a><span class=label>107. </span>&nbsp;<span class=citation><a name=d36060e3514 class=n-a></a>Oliveira-Ferrer L, Hauschild J, Fiedler W, <i> et al.</i>: Cilengitide induces cellular detachment and apoptosis in endothelial and glioma cells mediated by inhibition of FAK/src/AKT pathway. <i>J Exp Clin Cancer Res.</i> 2008; <b>27</b>: 86. <a target=xrefwindow id=d36060e3525 href="http://www.ncbi.nlm.nih.gov/pubmed/19114005">PubMed Abstract </a> | <a target=xrefwindow id=d36060e3528 href="http://dx.doi.org/10.1186/1756-9966-27-86">Publisher Full Text </a> | <a target=xrefwindow id=d36060e3532 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2648308">Free Full Text </a></span></li><li><a name=ref-108 class=n-a></a><span class=label>108. </span>&nbsp;<span class=citation><a name=d36060e3542 class=n-a></a>Mizejewski GJ: Role of integrins in cancer: survey of expression patterns. <i>Proc Soc Exp Biol Med.</i> 1999; <b>222</b>(2): 124â38. <a target=xrefwindow id=d36060e3550 href="http://www.ncbi.nlm.nih.gov/pubmed/10564536">PubMed Abstract </a> | <a target=xrefwindow id=d36060e3553 href="http://dx.doi.org/10.1046/j.1525-1373.1999.d01-122.x">Publisher Full Text </a></span></li><li><a name=ref-109 class=n-a></a><span class=label>109. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/7416956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d36060e3562 class=n-a></a>Ramirez NE, Zhang Z, Madamanchi A, <i> et al.</i>: The Î±<sub>2</sub>Î²<sub>1</sub> integrin is a metastasis suppressor in mouse models and human cancer. <i>J Clin Invest.</i> 2011; <b>121</b>(1): 226â37. <a target=xrefwindow id=d36060e3580 href="http://www.ncbi.nlm.nih.gov/pubmed/21135504">PubMed Abstract </a> | <a target=xrefwindow id=d36060e3583 href="http://dx.doi.org/10.1172/JCI42328">Publisher Full Text </a> | <a target=xrefwindow id=d36060e3586 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3007139">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/7416956">F1000 Recommendation</a></span></li><li><a name=ref-110 class=n-a></a><span class=label>110. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1018144"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d36060e3599 class=n-a></a>Wang H, Fu W, Im JH, <i> et al.</i>: Tumor cell alpha3beta1 integrin and vascular laminin-5 mediate pulmonary arrest and metastasis. <i>J Cell Biol.</i> 2004; <b>164</b>(6): 935â41. <a target=xrefwindow id=d36060e3610 href="http://www.ncbi.nlm.nih.gov/pubmed/15024036">PubMed Abstract </a> | <a target=xrefwindow id=d36060e3613 href="http://dx.doi.org/10.1083/jcb.200309112">Publisher Full Text </a> | <a target=xrefwindow id=d36060e3617 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2172296">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1018144">F1000 Recommendation</a></span></li><li><a name=ref-111 class=n-a></a><span class=label>111. </span>&nbsp;<span class=citation><a name=d36060e3630 class=n-a></a>Zhou B, Gibson-Corley KN, Herndon ME, <i> et al.</i>: Integrin Î±3Î²1 can function to promote spontaneous metastasis and lung colonization of invasive breast carcinoma. <i>Mol Cancer Res.</i> 2014; <b>12</b>(1): 143â54. <a target=xrefwindow id=d36060e3641 href="http://www.ncbi.nlm.nih.gov/pubmed/24002891">PubMed Abstract </a> | <a target=xrefwindow id=d36060e3644 href="http://dx.doi.org/10.1158/1541-7786.MCR-13-0184">Publisher Full Text </a> | <a target=xrefwindow id=d36060e3648 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3947021">Free Full Text </a></span></li><li><a name=ref-112 class=n-a></a><span class=label>112. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726785781"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d36060e3657 class=n-a></a>Varzavand A, Hacker W, Ma D, <i> et al.</i>: Î±3Î²1 Integrin Suppresses Prostate Cancer Metastasis via Regulation of the Hippo Pathway. <i>Cancer Res.</i> 2016; <b>76</b>(22): 6577â87. <a target=xrefwindow id=d36060e3668 href="http://www.ncbi.nlm.nih.gov/pubmed/27680681">PubMed Abstract </a> | <a target=xrefwindow id=d36060e3671 href="http://dx.doi.org/10.1158/0008-5472.CAN-16-1483">Publisher Full Text </a> | <a target=xrefwindow id=d36060e3675 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5290210">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726785781">F1000 Recommendation</a></span></li><li><a name=ref-113 class=n-a></a><span class=label>113. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725997923"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d36060e3688 class=n-a></a>Blandin AF, Renner G, Lehmann M, <i> et al.</i>: Î²1 Integrins as Therapeutic Targets to Disrupt Hallmarks of Cancer. <i>Front Pharmacol.</i> 2015; <b>6</b>: 279. <a target=xrefwindow id=d36060e3699 href="http://www.ncbi.nlm.nih.gov/pubmed/26635609">PubMed Abstract </a> | <a target=xrefwindow id=d36060e3702 href="http://dx.doi.org/10.3389/fphar.2015.00279">Publisher Full Text </a> | <a target=xrefwindow id=d36060e3706 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4656837">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725997923">F1000 Recommendation</a></span></li><li><a name=ref-114 class=n-a></a><span class=label>114. </span>&nbsp;<span class=citation><a name=d36060e3720 class=n-a></a>Campbell MR, Zhang H, Ziaee S, <i> et al.</i>: Effective treatment of HER2-amplified breast cancer by targeting HER3 and Î²1 integrin. <i>Breast Cancer Res Treat.</i> 2016; <b>155</b>(3): 431â40. <a target=xrefwindow id=d36060e3731 href="http://www.ncbi.nlm.nih.gov/pubmed/26860947">PubMed Abstract </a> | <a target=xrefwindow id=d36060e3734 href="http://dx.doi.org/10.1007/s10549-016-3698-y">Publisher Full Text </a> | <a target=xrefwindow id=d36060e3738 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4767608">Free Full Text </a></span></li><li><a name=ref-115 class=n-a></a><span class=label>115. </span>&nbsp;<span class=citation><a name=d36060e3747 class=n-a></a>Cerchia L, Giangrande PH, McNamara JO, <i> et al.</i>: Cell-specific aptamers for targeted therapies. <i>Methods Mol Biol.</i> 2009; <b>535</b>: 59â78. <a target=xrefwindow id=d36060e3758 href="http://www.ncbi.nlm.nih.gov/pubmed/19377980">PubMed Abstract </a> | <a target=xrefwindow id=d36060e3761 href="http://dx.doi.org/10.1007/978-1-59745-557-2_5">Publisher Full Text </a> | <a target=xrefwindow id=d36060e3765 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4443708">Free Full Text </a></span></li><li><a name=ref-116 class=n-a></a><span class=label>116. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726220676"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d36060e3774 class=n-a></a>Berg K, Lange T, Mittelberger F, <i> et al.</i>: Selection and Characterization of an Î±6Î²4 Integrin blocking DNA Aptamer. <i>Mol Ther Nucleic Acids.</i> 2016; <b>5</b>(3): e294. <a target=xrefwindow id=d36060e3785 href="http://www.ncbi.nlm.nih.gov/pubmed/26978578">PubMed Abstract </a> | <a target=xrefwindow id=d36060e3788 href="http://dx.doi.org/10.1038/mtna.2016.10">Publisher Full Text </a> | <a target=xrefwindow id=d36060e3792 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5014452">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726220676">F1000 Recommendation</a></span></li><li><a name=ref-117 class=n-a></a><span class=label>117. </span>&nbsp;<span class=citation><a name=d36060e3805 class=n-a></a>Camorani S, Crescenzi E, Gramanzini M, <i> et al.</i>: Aptamer-mediated impairment of EGFR-integrin Î±vÎ²3 complex inhibits vasculogenic mimicry and growth of triple-negative breast cancers. <i>Sci Rep.</i> 2017; <b>7</b>: 46659. <a target=xrefwindow id=d36060e3816 href="http://www.ncbi.nlm.nih.gov/pubmed/28425453">PubMed Abstract </a> | <a target=xrefwindow id=d36060e3819 href="http://dx.doi.org/10.1038/srep46659">Publisher Full Text </a> | <a target=xrefwindow id=d36060e3823 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5397976">Free Full Text </a></span></li><li><a name=ref-118 class=n-a></a><span class=label>118. </span>&nbsp;<span class=citation><a name=d36060e3832 class=n-a></a>Arruda MacÃªdo JK, Fox JW, de Souza Castro M: Disintegrins from snake venoms and their applications in cancer research and therapy. <i>Curr Protein Pept Sci.</i> 2015; <b>16</b>(6): 532â48. <a target=xrefwindow id=d36060e3840 href="http://www.ncbi.nlm.nih.gov/pubmed/26031306">PubMed Abstract </a> | <a target=xrefwindow id=d36060e3843 href="http://dx.doi.org/10.2174/1389203716666150515125002">Publisher Full Text </a> | <a target=xrefwindow id=d36060e3846 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4997955">Free Full Text </a></span></li><li><a name=ref-119 class=n-a></a><span class=label>119. </span>&nbsp;<span class=citation><a name=d36060e3855 class=n-a></a>Minea R, Helchowski C, Rubino B, <i> et al.</i>: Development of a chimeric recombinant disintegrin as a cost-effective anti-cancer agent with promising translational potential. <i>Toxicon.</i> 2012; <b>59</b>(4): 472â86. <a target=xrefwindow id=d36060e3866 href="http://www.ncbi.nlm.nih.gov/pubmed/21354198">PubMed Abstract </a> | <a target=xrefwindow id=d36060e3869 href="http://dx.doi.org/10.1016/j.toxicon.2011.02.020">Publisher Full Text </a> | <a target=xrefwindow id=d36060e3873 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3130806">Free Full Text </a></span></li><li><a name=ref-120 class=n-a></a><span class=label>120. </span>&nbsp;<span class=citation><a name=d36060e3883 class=n-a></a>Saviola AJ, Burns PD, Mukherjee AK, <i> et al.</i>: The disintegrin tzabcanin inhibits adhesion and migration in melanoma and lung cancer cells. <i>Int J Biol Macromol.</i> 2016; <b>88</b>: 457â64. <a target=xrefwindow id=d36060e3894 href="http://www.ncbi.nlm.nih.gov/pubmed/27060015">PubMed Abstract </a> | <a target=xrefwindow id=d36060e3897 href="http://dx.doi.org/10.1016/j.ijbiomac.2016.04.008">Publisher Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 31 Aug 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-1612.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-1612.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Regenerative and Cancer Cell Biology, Albany Medical College, Albany, New York, USA<br/> <sup>2</sup> Department of Surgery, Albany Medical College, Albany , New York, USA<br/> <p> <div class=margin-bottom> Whitney Longmate <br/> <span>Roles: </span> Conceptualization, Writing â Original Draft Preparation, Writing â Review & Editing </div> <div class=margin-bottom> C Michael DiPersio <br/> <span>Roles: </span> Conceptualization, Funding Acquisition, Writing â Original Draft Preparation, Writing â Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/6-1612/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 31 Aug 2017, 6:1612 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.11877.1">https://doi.org/10.12688/f1000research.11877.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> Â© 2017 Longmate W and DiPersio CM. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=12834 data-id=11877 data-downloads="" data-views="" data-scholar="10.12688/f1000research.11877.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/6-1612/v1/pdf?article_uuid=199d194a-69bb-4c20-bb56-c5112e8f13c4" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.11877.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Longmate W and DiPersio CM. Beyond adhesion:&nbsp;emerging roles for integrins in control of the tumor microenvironment [version 1; peer review: 4 approved] <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1612 (<a href="https://doi.org/10.12688/f1000research.11877.1" target=_blank>https://doi.org/10.12688/f1000research.11877.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=11877 id=mobile-track-article-signin-11877 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/11877?target=/articles/6-1612.html"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=12834 /> <input name=articleId type=hidden value=11877 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Kathleen L O'Connor</strong>, Markey Cancer Center, University of Kentucky, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Johanna Ivaska</strong>, Department of Biochemistry and Food Chemistry, University of Turku, Finland </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Nils Cordes</strong>, National Center for Radiation Research in Oncology, University Hospital Carl Gustav Carus Dresden, Germany </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Jonathan Jones</strong>, School of Molecular Biosciences, Washington State University, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 31 Aug 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-1612.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-1612.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=25475-25541></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=25474-25543></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=25476-25542></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=25477-25540></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=4><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> <th class="c-report-timeline__headings-version p-article__color--dark">3</th> <th class="c-report-timeline__headings-version p-article__color--dark">4</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/6-1612/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>31 Aug 17</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Kathleen L O'Connor</strong>, Markey Cancer Center, University of Kentucky, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Johanna Ivaska</strong>, Department of Biochemistry and Food Chemistry, University of Turku, Finland </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Nils Cordes</strong>, National Center for Radiation Research in Oncology, University Hospital Carl Gustav Carus Dresden, Germany </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Jonathan Jones</strong>, School of Molecular Biosciences, Washington State University, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/6-1612.html&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/6-1612/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Beyond adhesion:\u00A0emerging roles for...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/6-1612/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/6-1612/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/6-1612/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Longmate W and DiPersio CM');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/6-1612/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/6-1612",
            templates : {
                twitter : "Beyond adhesion:\u00A0emerging roles for integrins in control.... Longmate W and DiPersio CM, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/6-1612/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Beyond adhesion:\u00A0emerging roles for integrins in control of the tumor microenvironment", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Beyond adhesion:\u00A0emerging roles for integrins in control of the tumor microenvironment", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/11877/12834")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "12834");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "25540": 0,
                           "25541": 1,
                           "25542": 0,
                           "25543": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "bfc3280d-4ac7-4a57-91c6-3a08b04933df";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1612.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1612.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1612.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/6-1612.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/6-1612.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>